{"paper_id":"17f039c0-ee6f-4263-9486-b45bb8d16ed0","body_text":"An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return\"[object Function]\"==o.call(a)}function e(a){return\"string\"==typeof a}function f(){}function g(a){return!a||\"loaded\"==a||\"complete\"==a||\"uninitialized\"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){(\"c\"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){\"img\"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),\"object\"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height=\"0\",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),\"img\"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||\"j\",e(a)?i(\"c\"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName(\"script\")[0],o={}.toString,p=[],q=0,r=\"MozAppearance\"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&\"[object Opera]\"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?\"object\":l?\"script\":\"img\",v=l?\"script\":u,w=Array.isArray||function(a){return\"[object Array]\"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split(\"!\"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split(\"=\"),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(\".\").pop().split(\"?\").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split(\"/\").pop().split(\"?\")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&\"css\"==i.url.split(\".\").pop().split(\"?\").shift()?\"c\":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation Jong-Sun Lee , Tu Dan , He Zhang , Yujing Cheng , Frederick Rehfeld , James Brugarolas , View ORCID Profile Joshua T. Mendell doi: https://doi.org/10.1101/2024.07.23.604857 Jong-Sun Lee 1 Department of Molecular Biology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tu Dan 2 Department of Radiation Oncology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site He Zhang 3 Quantitative Biomedical Research Center, Peter O’Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yujing Cheng 1 Department of Molecular Biology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Frederick Rehfeld 1 Department of Molecular Biology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site James Brugarolas 4 Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA 5 Kidney Cancer Program, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA 6 Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joshua T. Mendell 1 Department of Molecular Biology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA 6 Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA 7 Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA 8 Howard Hughes Medical Institute, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Joshua T. Mendell For correspondence: Joshua.Mendell{at}UTSouthwestern.edu Abstract Full Text Info/History Metrics Supplementary material Preview PDF ABSTRACT Cancer cells frequently upregulate ribosome production to support tumorigenesis. While small nucleolar RNAs (snoRNAs) are critical for ribosome biogenesis, the roles of other classes of noncoding RNAs in this process remain largely unknown. Here we performed CRISPRi screens to identify essential long noncoding RNAs (lncRNAs) in renal cell carcinoma (RCC) cells. This revealed that an alternatively-spliced isoform of lncRNA Colorectal Neoplasia Differentially Expressed containing an ultraconserved element (UCE), referred to as CRNDE UCE , is required for RCC cell proliferation. CRNDE UCE localizes to the nucleolus and promotes 60S ribosomal subunit biogenesis. The UCE of CRNDE functions as an unprocessed C/D box snoRNA that directly interacts with ribosomal RNA precursors. This facilitates delivery of eIF6, a key 60S biogenesis factor, which binds to CRNDE UCE through a sequence element adjacent to the UCE. These findings highlight the functional versatility of snoRNA sequences and expand the known mechanisms through which noncoding RNAs orchestrate ribosome biogenesis. INTRODUCTION Uncontrolled cell growth and proliferation in cancer is fueled by high levels of translation, which necessitates an abundance of ribosomes 1 . To fulfill this heightened demand, cancer cells frequently exploit the intricate regulatory networks governing ribosome biogenesis 2 , 3 . For example, key drivers of growth and proliferation, such as the oncogenic transcription factor MYC and the mTOR pathway, stimulate ribosome biogenesis by increasing ribosomal RNA (rRNA) transcription, ribosomal protein translation, and ribosome assembly 4 , 5 . These pathways are highly active in many tumor types, including renal cell carcinoma (RCC), a deadly malignancy with the highest mortality rate among genitourinary cancers 6 , 7 . It has been recognized for more than a century that cancer cells frequently exhibit an increase in the size and abundance of nucleoli, the site of ribosome assembly 8 , 9 . This phenomenon is particularly striking in RCC, where nucleolar prominence is a key determinant of tumor grade 10 . These observations suggest that pathways that drive aberrant ribosome biogenesis may represent a therapeutic liability that can be exploited in RCC and other malignancies. Ribosome biogenesis is a highly-regulated process that begins in the nucleolus with transcription of 47S precursor ribosomal RNA (pre-rRNA), which is processed to produce the mature 18S, 5.8S, and 28S rRNAs 11 , 12 . Coupled to each step of pre-rRNA processing is the sequential addition of ribosomal proteins, ultimately generating the 40S and 60S ribosomal subunits. This process is guided by a large suite of assembly factors (AFs) and closely monitored by multiple checkpoint and surveillance pathways that enable the tightly-controlled production of functional ribosomes 13 . The maturation of the 60S subunit in particular is a complex process involving nucleolar, nucleoplasmic, and cytoplasmic assembly stages 14 . A central player in 60S biogenesis is eukaryotic initiation factor 6 (eIF6), a highly conserved protein that is essential for 60S assembly across species 15 . In Saccharomyces cerevisiae and mammalian cells, eIF6 (known as TIF6 in yeast) associates with pre-60S subunits in the nucleolus, where it promotes rRNA processing and 60S subunit maturation before export of the subunit to the cytoplasm 16 – 18 . During the final stages of 60S biogenesis in the cytoplasm, eIF6 acts as a ribosome anti-association factor, preventing premature association of 60S subunits with 40S subunits 19 – 21 . Eviction of eIF6 from mature 60S subunits, which is required for the assembly of actively translating 80S ribosomes, is mediated by the Shwachman-Bodian-Diamond syndrome protein (SBDS) and the GTPase elongation factor-like 1 (EFL1) 22 – 24 . Following its release, eIF6 shuttles back to the nucleus, where it is recycled for further rounds of 60S subunit biogenesis. Underscoring the importance of this step of ribosome maturation, deficiency of SBDS or EFL1 causes Shwachman-Diamond Syndrome (SDS), a rare inherited ribosomopathy characterized by bone marrow failure, pancreatic insufficiency, skeletal abnormalities, and predisposition to hematopoietic malignancies 25 – 27 . Noncoding RNAs also play key roles in ribosome biogenesis. In particular, small nucleolar RNAs (snoRNAs), a family of ∼60-250 nucleotide RNAs, serve as guides for site-specific chemical modification of rRNA and are critical for proper ribosome assembly and function 28 . snoRNAs can be classified into two major groups: C/D box snoRNAs, which guide 2’- O -methylation, and H/ACA box snoRNAs, which guide pseudouridylation. Each family of snoRNAs associates with a distinct set of co-factors to produce the functional snoRNA ribonucleoprotein particles (snoRNPs) that install the modifications in pre-rRNA. In addition to guiding nucleotide modifications, some snoRNAs promote pre-rRNA processing 29 , illustrating how base-pairing interactions between snoRNAs and rRNA orchestrate multiple aspects of ribosome biogenesis. In metazoans, the vast majority of snoRNAs are encoded in introns of messenger RNAs (mRNAs) or noncoding RNAs 29 , 30 . After excision of the snoRNA-containing intron and debranching, exonucleolytic trimming from the 5’ and 3’ ends produces the mature snoRNA sequence, which is protected by association with snoRNP components. Interestingly, when two snoRNA sequences are present in a single intron, longer noncoding RNAs can be produced, with the tandem snoRNAs at each end protecting the intervening sequence from degradation 31 . One such noncoding RNA, termed SLERT , promotes pre-rRNA transcription 32 . Another lncRNA, known as LoNA , contains an unprocessed C/D box snoRNA-like element that negatively regulates 2’- O -methylation of pre-rRNA by sequestering snoRNP components 33 . These examples underscore the diversity of mechanisms through which snoRNA-like sequences can regulate ribosome biogenesis. Whether additional snoRNA-related RNAs, or other classes of noncoding RNAs, directly participate in later stages of ribosome assembly remains unknown. In this study, we set out to identify long noncoding RNA (lncRNAs), a class of noncoding RNAs >200 nucleotides in length with diverse functions 34 , that are essential for growth of RCC cells. To this end, CRISPR interference (CRISPRi) screens were performed in multiple RCC cell lines, using a custom sgRNA library targeting approximately 750 lncRNAs that are overexpressed in this tumor type. These screens revealed that the lncRNA Colorectal Neoplasia Differentially Expressed ( CRNDE ) is essential for proliferation of all tested RCC cell lines. While CRNDE overexpression is linked to many cancers 35 – 38 , we discovered that a distinct isoform containing an ultraconserved element (UCE), termed CRNDE UCE , is essential in RCC cells. We further demonstrated that CRNDE UCE localizes to the nucleolus and is required for the biogenesis of 60S ribosomal subunits. We found that the UCE in CRNDE functions as an unprocessed C/D box snoRNA-like element, associating with snoRNP components and directly interacting with 32S pre-rRNA. This interaction facilitates the delivery of eIF6, which binds to a sequence element adjacent to the UCE in CRNDE UCE , to pre-60S subunits, thus promoting ribosome biogenesis. Together, these findings illuminate the diverse mechanisms through which noncoding RNAs and snoRNA sequences impact ribosome biogenesis and illustrate how these functions are co-opted in cancer. RESULTS CRISPRi screening reveals that CRNDE is required for proliferation of RCC cells Despite advances in targeted therapies and immunotherapies, RCC remains a deadly disease 39 , 40 , underscoring the need to identify new targets and pathways that drive this malignancy. Given their potential to function as oncogenic drivers 41 , we sought to systematically identify lncRNAs that are essential for proliferation and survival of RCC cells. To achieve this, we first generated a comprehensive catalog of lncRNAs that are highly expressed in this tumor type. RNA-seq data from a well-curated set of matched RCC tumor-normal pairs collected at UT Southwestern 42 – 44 , as well as RCC data from The Cancer Genome Atlas (TCGA) 45 , was analyzed to identify overexpressed lncRNAs ( Figures 1A and S1A ). These candidate lncRNAs were further filtered by selecting those that were detectably expressed in kidney cancer cell lines, as documented by the Cancer Cell Line Encyclopedia (CCLE) 46 . We also included 181 additional lncRNAs, representing the most highly expressed lncRNAs in RCC patient tumor samples not already selected. This yielded a final set of 753 genes, comprising the most overexpressed and abundant lncRNAs in RCC ( Table S1 ). Download figure Open in new tab Figure 1. CRISPRi screening reveals that CRNDE is required for proliferation of RCC cells ( A ) RNA-seq analysis of 48 matched tumor-normal pairs from RCC patients. The highlighted box indicates the lncRNAs whose expression level is at least 2-fold higher in tumors (FDR<0.05). ( B ) Schematic of CRISPRi drop-out screens performed in RCC cell lines. ( C ) MAGeCK analysis of CRISPRi screens. The common essential lncRNAs that were among the top 50 hits in all RCC cell lines are indicated. ( D ) TCGA (left) and UTSW RNA-seq data (right) showing elevated expression of CRNDE in RCC tumors. KIRC, Renal Clear Cell Carcinoma; KIRP, Renal Papillary Cell Carcinoma; RCC, all renal cell carcinoma subtypes. ( E ) qRT-PCR analysis of CRNDE expression relative to GAPDH in 786-O CRISPRi cells after lentiviral expression of non-target (sgNT) or CRNDE -targeting sgRNAs (left). Proliferation was measured by cell counts at the indicated timepoints after plating (right). ( F ) Fluorescence microscopy (left) and quantification (right) of DAPI and EdU incorporation in 786-O CRISPRi cells expressing the indicated sgRNAs. ( G ) qRT-PCR analysis of CRNDE expression relative to GAPDH in patient-derived primary RCC CRISPRi cells after lentiviral expression of non-target (sgNT) or CRNDE -targeting sgRNAs (left). Proliferation was measured by cell counts at the indicated timepoints after plating (right). Data are represented as mean ± SD (n=3 biological replicates). *p<0.05, **p<0.01, calculated by two-tailed t-test. See also Figure S1. We next performed CRISPRi screens in multiple RCC cell lines (786-O, A-498, and ACHN), representing the most common RCC subtypes and molecular alterations 47 , to determine which of these lncRNAs are essential for RCC cell viability and/or proliferation. A lentiviral single guide RNA (sgRNA) library targeting the 753 candidate lncRNAs, consisting of approximately 10 sgRNAs per transcription start site (TSS), was constructed ( Figure 1B and Table S1 ). sgRNAs targeting a set of known essential genes were included as positive controls. Stable cell lines expressing nuclease-deficient Cas9 fused to the KRAB transcriptional repressor domain (dCas9-KRAB) were generated, transduced with the library at high coverage (>1000 cells per sgRNA), and cultured for 10 population doublings. High-throughput sequencing was then performed and analyzed using MAGeCK 48 to identify essential lncRNAs, representing those targeted by multiple sgRNAs that dropped out after prolonged passaging. As expected, positive control sgRNAs targeting common essential genes were strongly depleted in all cell lines, demonstrating technical success of the screens ( Figure S1B ). Among the targeted lncRNAs, only three were shared among the top 50 most depleted lncRNAs in all three RCC cell lines: MFI2-AS1 , RP11-290D2.6 , and CRNDE ( Figure 1C and Table S2 ). Both MFI2-AS1 and RP11-290D2.6 are antisense transcripts that fully overlap protein-coding genes, suggesting that silencing their expression is likely to impact the overlapping genes in cis . We therefore focused on CRNDE due to its potential to function through a trans -acting mechanism. CRNDE is a well-conserved intergenic lncRNA that has previously been shown to be overexpressed in many types of cancer, including RCC 35 – 38 . Indeed, analysis of TCGA and UT Southwestern RNA-seq data confirmed that CRNDE is strongly overexpressed in RCC ( Figure 1D ), and high expression is associated with poor patient survival ( Figure S1C ). These findings suggested an oncogenic role for CRNDE in RCC. As predicted from the screening results and previous studies using short-hairpin-mediated knockdown 38 , depletion of CRNDE using CRISPRi strongly inhibited growth of all tested RCC cell lines ( Figures 1E , S1D, and S1E ). Incorporation of 5-ethynyl-2’-deoxyuridine (EdU) was reduced in CRNDE -deficient cells, indicative of reduced DNA replication ( Figure 1F ), while cleaved caspase-3, a marker of programmed cell death, remained undetectable ( Figure S1F ). Thus, loss of CRNDE impairs RCC cell proliferation without triggering apoptosis. We further showed that CRISPRi-mediated silencing of CRNDE impaired growth of multiple lines of primary patient-derived RCC cells ( Figures 1G and S1G ), demonstrating that the requirement for CRNDE is not limited to established RCC cell lines. Altogether, these results documented an essential role for CRNDE in RCC cell proliferation. A CRNDE isoform containing an ultraconserved element promotes RCC proliferation in trans Although there is an extensive body of literature demonstrating that CRNDE knockdown impairs the proliferation and survival of many cancer cell lines 37 , no consensus exists regarding the molecular function of this lncRNA. LncRNAs may act by regulating local gene expression in cis , or they may leave the site of transcription and perform functions in trans 49 , 50 . The TSS of CRNDE is located ∼2 kilobases (kb) from the TSS of Iroquois Homeobox 5 ( IRX5 ) (Figure S1H ), while no other genes are located within hundreds of kb of this locus. Importantly, CRISPRi-mediated knockdown of CRNDE did not affect expression of IRX5 mRNA or protein ( Figures S1I and S1J ), arguing against local gene regulation by this lncRNA. To test whether CRNDE functions in trans , we performed rescue experiments by expressing CRNDE in 786-O cells using a doxycycline (dox)-inducible PiggyBac transposon vector 51 . Expression of the full-length, unspliced CRNDE sequence rescued cell proliferation upon knockdown of endogenous CRNDE , demonstrating that a transcript produced from this locus supports RCC cell growth in trans ( Figures 2A and S2A ). Surprisingly, introduction of the fully-spliced CRNDE transcript was unable to rescue cell growth ( Figures 2A and S2B ), suggesting that this function might be attributable to an alternatively-spliced CRNDE isoform. Interestingly, analysis of ENCODE RNA-seq data revealed an abundance of reads spanning the final three introns of CRNDE , suggesting inefficient splicing ( Figure 2B ). Indeed, publicly-available long-read RNA sequencing data confirmed the expression of alternatively-spliced CRNDE isoforms containing these introns in multiple tissues ( Figure 2C ). Notably, these intron-containing transcripts harbored an ultraconserved element (UCE), a sequence of at least 200 nucleotides in length that exhibits extreme conservation among vertebrates 52 , 53 ( Figure 2D ). Transcripts containing the alternatively-spliced introns were readily detectable by oligo dT-primed RT-PCR in 786-O cells ( Figure S2C ), while northern blotting using a probe complementary to the UCE confirmed the expression of a ∼5 kb CRNDE isoform containing this element ( Figure 2E ). Copy number analysis in RCC and other human cell lines documented the abundant expression of UCE-containing CRNDE transcripts in the range of ∼50-300 copies per cell ( Figure S2D ). Rescue experiments using the alternatively-spliced ∼5 kb CRNDE isoform containing the UCE demonstrated that expression of this transcript was sufficient to rescue proliferation upon knockdown of endogenous CRNDE ( Figure 2F ). Moreover, isolated expression of the third intron of CRNDE containing the UCE, or truncated versions with ∼800 nucleotides removed from the 5’ or 3’ ends, also supported cell proliferation ( Figures 2G , 2H , S2E, and S2F ; UCE intron, UCE intron 5’ deletion, or UCE intron 3’ deletion). Notably, the UCE alone or an upstream intron fragment lacking the UCE was not able to rescue growth ( Figures 2G , 2H and S2F ; UCE and UCE intron upstream). Together, these data demonstrated that an alternatively-spliced CRNDE isoform containing a UCE, hereafter referred to as CRNDE UCE , is required for RCC cell proliferation. Download figure Open in new tab Figure 2. A CRNDE isoform containing an ultraconserved element promotes RCC proliferation in trans ( A ) Proliferation of 786-O CRISPRi cells expressing doxycycline (dox)-inducible unspliced (left) or fully-spliced (right) CRNDE rescue constructs after lentiviral expression of non-target sgRNA (sgNT) or sgRNA targeting endogenous CRNDE . ( B-D ) UCSC genome browser ENCODE transcription (B) and vertebrate conservation (PhastCons) (D) tracks (hg38), aligned with intron-containing CRNDE isoforms detected in the PacBio Universal Human Reference RNA dataset 74 (C). ( E ) Northern blot analysis of total RNA from the indicated cell lines after lentiviral expression of non-target (sgNT) or CRNDE -targeting sgRNAs using a probe complementary to the UCE. ( F ) qRT-PCR analysis (bottom left) and proliferation (bottom right) of 786-O CRISPRi cells expressing a dox-inducible CRNDE UCE-containing isoform rescue construct after lentiviral expression of non-target sgRNA (sgNT) or sgRNA targeting endogenous CRNDE . The positions of qRT-PCR amplicons (A, B, C, D, and E) are indicated in the transcript schematic. Transcript abundance was normalized to GAPDH . ( G-H ) Schematic showing positions of UCE intron rescue constructs (G) and their ability to support proliferation upon depletion of endogenous CRNDE , as measured by cell counts six days after plating (H). Data are represented as mean ± SD (n=3 biological replicates). n.s., not significant; **p<0.01, calculated by two-tailed t-test. See also Figure S2. CRNDE UCE localizes to the nucleolus and promotes 60S ribosomal subunit biogenesis To elucidate the molecular function of CRNDE UCE underlying its requirement for cell proliferation, we next examined its subcellular localization. Cellular fractionation demonstrated that the fully-spliced CRNDE isoform localizes primarily to the cytoplasm in RCC cells, as reported in other cell types 54 , 55 ( Figures 3A and S3A ). CRNDE UCE , in contrast, was highly enriched in nuclear fractions. Moreover, RNA fluorescence in situ hybridization (FISH) using probes complementary to the UCE revealed strong localization to the nucleolus ( Figure 3B ). To further validate nucleolar localization of CRNDE UCE , we performed pre-ribosome sequential extraction (PSE), which enables isolation of cytoplasmic and nucleoplasmic components (SN1 fraction), nucleolar ribosomes and associated components at late stages of maturation (SN2 fraction), and early pre-ribosomes near the core of the nucleolus (SN3 fraction) ( Figures 3C and 3D ) 56 , 57 . Analysis of CRNDE UCE abundance in these fractions verified its strong enrichment in the nucleolar interior (SN3) along with 32S pre-rRNA, a marker of early pre-ribosomes ( Figures 3E and S3B ). Download figure Open in new tab Figure 3. CRNDE UCE localizes to the nucleolus and promotes 60S ribosomal subunit biogenesis ( A ) Subcellular fractionation and qRT-PCR analysis of 786-O cells using primers that detect fully-spliced CRNDE ( CRNDE spliced ), CRNDE UCE-containing isoforms ( CRNDE UCE ), or all CRNDE isoforms ( CRNDE total ). GAPDH and MALAT1 represent cytoplasmic and nuclear controls, respectively. ( B ) RNA FISH with a probe complementary to the UCE (red) in 786-O CRISPRi cells expressing the indicated sgRNAs. ( C ) Schematic of pre-ribosomal sequential extraction showing stages of ribosome biogenesis captured in each fraction (SN1, SN2, SN3). FC, fibrillar center; DFC, dense fibrillar component; GC, granular component; Nu, nucleoplasm; Cy, cytoplasm. ( D ) Western blot analysis of control proteins in nucleolar fractions. ( E ) qRT-PCR analysis of CRNDE UCE in nucleolar fractions from 786-O cells. GAPDH and 32S pre-rRNA represent cytoplasmic and early nucleolar markers, respectively. ( F-H ) Schematic of polysome profiling by sucrose gradient ultracentrifugation (F) and results from 786-O (G) and HeLa (H) CRISPRi cells after lentiviral expression of non-target (sgNT) or CRNDE -targeting sgRNAs. Data are represented as mean ± SD (n=3 biological replicates). See also Figure S3. Given that the nucleolus is the major site of ribosome biogenesis, we next examined the impact of loss of CRNDE on ribosomal subunit abundance and translation. Using sucrose density gradient ultracentrifugation, we observed that CRNDE deficiency resulted in a significant decrease in the levels of mature 60S subunits and a collapse of translating polysomes, while minimally affecting the abundance of 40S subunits ( Figures 3F , 3G and S3C ). To extend these analyses beyond RCC cells, we also examined CRNDE localization and function in HeLa cells and TERT-immortalized human fibroblasts (BJ). Depletion of CRNDE in these cell lines also impaired cell proliferation and measurably reduced 60S ribosomal subunit abundance, albeit to a lesser extent than in RCC cells ( Figures 3H and S3D-F ). Fractionation experiments demonstrated that CRNDE UCE was similarly enriched within the nucleolar interior in these cells ( Figures S3G and S3H ). These data established that CRNDE UCE is a nucleolar transcript that promotes the biogenesis of 60S ribosomal subunits in RCC and other cell types. CRNDE UCE interacts directly with the 60S biogenesis factor eIF6 To determine how CRNDE UCE promotes 60S ribosomal subunit biogenesis, we performed RNA antisense purification followed by mass spectrometry (RAP-MS) from UV-crosslinked RCC cells, which enables the identification of endogenous proteins that interact with a target RNA of interest 58 . To enhance the efficiency of detection of interacting proteins, we employed organic phase separation to enrich crosslinked RNPs prior to RNA pull-down 59 , 60 ( Figures 4A and S4A ). Endogenous CRNDE UCE RNP complexes were efficiently recovered using biotinylated antisense oligonucleotides (ASOs) complementary to the UCE region and co-purifying proteins were identified by mass spectrometry ( Figures S4B and S4C ). Notably, eIF6, a key factor in 60S ribosomal subunit biogenesis, was the most abundant protein uniquely detected in CRNDE UCE pull-downs but not detected in control pull-downs. A direct interaction between CRNDE UCE and eIF6 was confirmed by ASO-mediated pull-down of the crosslinked CRNDE UCE RNP under denaturing conditions followed by western blotting ( Figure 4B ). Endogenous CRNDE UCE was also highly enriched following reciprocal immunoprecipitation of endogenous eIF6 ( Figure 4C ). Download figure Open in new tab Figure 4. CRNDE UCE interacts directly with the 60S biogenesis factor eIF6 ( A ) Schematic of UV-crosslinking and purification of endogenous CRNDE UCE to identify interacting proteins by mass spectrometry. ( B ) Western blot of eIF6 after UV crosslinking and pull-down of CRNDE UCE with ASOs under denaturing conditions. Scrambled ASO served as a negative control. ( C ) qRT-PCR analysis of CRNDE UCE or GAPDH after UV-crosslinking and immunoprecipitation with anti-eIF6 antibody or control IgG. Fold enrichment over IgG plotted. Data are represented as mean ± SD (n=3 biological replicates). **p<0.01, calculated by two-tailed t-test. ( D-E ) Schematics of CRNDE UCE intron fragment (D, upper) or sub-fragments (E, upper) used in EMSAs with eIF6 (lower panels). See also Figure S4. To further establish that eIF6 interacts directly with CRNDE UCE , electrophoretic mobility shift assays (EMSAs) were performed using in vitro transcribed UCE-containing intron fragments and purified Flag-tagged eIF6 ( Figure S4D ). eIF6 bound to the full-length UCE-containing intron ( Figure 4D ) as well as to a sub-fragment comprising the region immediately upstream of the UCE ( Figure 4E ; F3). We further narrowed the binding site to a 200-nucleotide sequence adjacent to the UCE ( Figure 4E ; F3-2). These results were consistent with our rescue experiments, which indicated that inclusion of the region upstream of the UCE was required to support growth of RCC cells ( Figures 2G , 2H and S2F ). These data raised the possibility that CRNDE UCE promotes 60S biogenesis by regulating the activity of eIF6. CRNDE UCE promotes loading of eIF6 onto pre-60S subunits in the nucleolus Depletion of CRNDE UCE had no effect on eIF6 mRNA or protein abundance ( Figures S5A and S5B ). Immunofluorescence, however, revealed a dramatic accumulation of eIF6 in nucleoli of CRNDE -depleted cells ( Figure 5A ). eIF6 is loaded onto pre-60S subunits in the nucleolus and it remains associated with 60S subunits until the final stages of maturation in the cytoplasm 15 – 21 . Therefore, the observed nucleolar accumulation of eIF6 in CRNDE -deficient cells suggested a defect in loading onto pre-ribosomes and/or export of pre-60S subunits to the cytoplasm. Download figure Open in new tab Figure 5. CRNDE UCE promotes the loading of eIF6 onto pre-60S subunits in the nucleolus ( A ) Immunolocalization of eIF6 in 786-O CRISPRi cells expressing the indicated sgRNAs. ( B-C ) Sucrose gradient fractionation of nucleoli from 786-O CRISPRi cells expressing sgRNAs targeting eIF6 (B) or CRNDE (C, upper). Western blot analysis of eIF6 in nucleolar fractions (C, lower). ( D ) Western blot analysis of input and eIF6 immunoprecipitates from 786-O CRISPRi cells expressing the indicated sgRNAs. ( E ) Schematic of pre-rRNA processing in human cells (left). Northern blot analysis of rRNA precursors with ITS1 and ITS2 probes in total RNA from 786-O cells (right). EtBr, ethidium bromide. ( F ) Schematic of SNAP labeling approach to detect newly synthesized large ribosomal subunits. ( G ) Fluorescence microscopy of newly-synthesized RPL23a-SNAP in 786-O CRISPRi cells expressing the indicated sgRNAs. ( H ) Western blot analysis of 786-O CRISPRi cells expressing RPL23a-SNAP and the indicated sgRNAs. ( I ) Western blot analysis of NMD3 or control IgG immunoprecipitates from 786-O CRISPRi cells expressing the indicated sgRNAs. See also Figure S5. To examine eIF6 loading onto pre-60S subunits, we performed sucrose gradient fractionation of purified nucleoli. As expected, depletion of eIF6 led to a marked accumulation of pre-60S subunits in nucleoli, with only a minor impact on pre-40S subunit abundance ( Figure 5B ). Loss of CRNDE phenocopied these effects, providing additional evidence for an early block in large subunit maturation in cells deficient for this lncRNA ( Figure 5C , upper). Western blotting further revealed a significant re-distribution of eIF6 from pre-60S fractions to ribosome-free fractions in CRNDE knockdown cells ( Figure 5C , lower). Accordingly, immunoprecipitation demonstrated a reduced association of eIF6 with the large ribosomal subunit protein RPL23 upon depletion of CRNDE ( Figure 5D ). These data supported a role for CRNDE UCE in promoting the loading of eIF6 onto pre-60S subunits. eIF6 loading is coupled to subsequent pre-rRNA processing steps within the pre-60S subunit; specifically cleavage of 27S pre-rRNA in yeast and 32S pre-rRNA in human cells 17 , 61 . We therefore examined pre-rRNA processing intermediates in CRNDE -deficient cells using northern blotting. Consistent with the observed defect in eIF6 loading, we detected a strong accumulation of 32S pre-rRNA, along with a corresponding decrease in 12S pre-rRNA, in both total and nucleolar fractions ( Figures 5E and S5C ). eIF6 loading is also required for the export of pre-60S subunits to the cytoplasm. To examine this step in ribosome biogenesis, we expressed a SNAP-tagged RPL23a protein that enabled specific labeling of newly-assembled pre-60S subunits whose trafficking from nucleoli could be monitored over time 62 ( Figures 5F and 5H ). After quenching pre-existing RPL23a-SNAP with a non-fluorescent benzyl-guanine substrate that reacts with the SNAP tag, newly-synthesized RPL23a-SNAP was labeled with Oregon Green and tracked by fluorescence microscopy. Loss of CRNDE resulted in a robust accumulation of newly-synthesized RPL23a-SNAP within nucleoli to an extent comparable to that observed upon depletion of SBDS, whose loss traps eIF6 in the cytoplasm and is known to result in a pre-60S export defect 23 ( Figure 5G ). Furthermore, immunoprecipitation of the pre-60S export factor NMD3 revealed a reduced association with eIF6 upon CRNDE depletion, suggesting impaired formation of pre-60S export complexes ( Figure 5I ). Altogether, these data strongly supported a role for CRNDE UCE in facilitating the loading of eIF6 onto maturing pre-60S subunits in the nucleolus, resulting in a defect in subsequent steps in ribosome biogenesis upon loss of this lncRNA. The CRNDE UCE is a C/D box snoRNA-like sequence that directly interacts with 32S pre-rRNA We next investigated how the interaction of eIF6 with CRNDE UCE promotes its loading onto pre-60S subunits. Given the key roles of snoRNAs in ribosome biogenesis, which base-pair with specific sites in pre-rRNA to guide nucleotide modifications and processing 28 , we hypothesized that CRNDE UCE may similarly base-pair with pre-rRNA in order to facilitate eIF6 delivery to maturing pre-ribosomes. To examine this possibility, 786-O cells were treated with 4’-aminomethyltrioxalen (AMT), a psoralen-derived crosslinker that induces interstrand crosslinks between base-paired RNAs upon exposure to UV light 63 . CRNDE UCE complexes were then selectively captured using biotinylated ASOs complementary to the UCE, subjected to stringent washing in urea-containing denaturing buffers 64 , and analyzed by qRT-PCR ( Figure 6A ). Remarkably, a robust enrichment of 32S pre-rRNA was detected in CRNDE UCE pull-down samples, while mature 18S or 28S rRNA, or an unrelated mRNA ( GAPDH ), exhibited minimal enrichment ( Figure 6B ). Use of a scrambled ASO, or pull-downs performed in the absence of AMT crosslinking ( Figure S5D ), yielded no enrichment, further demonstrating the specificity of the 32S pre-rRNA signal in CRNDE UCE purifications. Additionally, the CRNDE UCE :32S pre-rRNA interaction occurred independently of eIF6, as demonstrated by pull-down assays performed following eIF6 depletion by CRISPRi ( Figure 6C ). These results supported a direct base-pairing interaction between CRNDE UCE and 32S pre-rRNA. Download figure Open in new tab Figure 6. The CRNDE UCE is a C/D box snoRNA-like element that base pairs with 32S pre-rRNA ( A ) Schematic of AMT crosslinking experiment to detect RNA:RNA base-pairing interactions. ( B-C ) qRT-PCR analysis of the indicated transcripts after AMT crosslinking and pull-down of CRNDE UCE with ASOs under denaturing conditions. Experiments were performed in parental 786-O CRISPRi cells (B) or in 786-O CRISPRi cells expressing non-target (sgNT) or eIF6-targeting sgRNAs (C). Scrambled ASO served as a negative control. Enrichment was normalized to input. ( D ) The UCE of CRNDE resembles a C/D box snoRNA. Putative C box, D box, and complementarity to 32S pre-rRNA indicated. ( E ) qRT-PCR analysis of negative control transcripts ( ACTB , NORAD , H/ACA box snoRNA SNORA13), 32S pre-rRNA (positive control), or CRNDE transcripts ( CRNDE UCE or CRNDE LastExon ) in FBL immunoprecipitates from UV-crosslinked 786-O cells. Fold enrichment over IgG plotted. ( F ) Western blot analysis of C/D box snoRNP components FBL and 15.5K, or H/ACA box snoRNP component DKC1, after UV crosslinking and pull-down of CRNDE UCE with ASOs under denaturing conditions. Scrambled ASO served as a negative control. ( G ) Schematic of CRNDE UCE intron fragments and sequence of 32S binding site mutant used in rescue experiments. ( H-I ) qRT-PCR analysis of the indicated transcripts after AMT crosslinking and pull-down of CRNDE UCE from cells expressing wild-type (H) or mutant (I) UCE-containing intron fragments after depletion of endogenous CRNDE using CRISPRi. ( J ) Proliferation of 786-O CRISPRi cells expressing wild-type or mutant UCE-containing intron fragments after lentiviral expression of non-target sgRNA (sgNT) or sgRNA targeting endogenous CRNDE . ( K ) Regulation of 60S ribosomal subunit biogenesis by CRNDE UCE . The UCE functions as an unprocessed C/D box snoRNA that base-pairs with 32S pre-rRNA. This facilitates delivery of eIF6, bound to an adjacent sequence element, to maturing pre-60S subunits, thereby promoting subsequent steps in 60S biogenesis. Data are represented as mean ± SD (n=3 biological replicates). n.s., not significant; **p<0.01, calculated by two-tailed t-test. See also Figure S5 and S6. We next sought to identify the region of CRNDE UCE that base-pairs with 32S pre-rRNA. Intriguingly, we noticed that the CRNDE locus exhibits multiple blocks of intronic sequence conservation, a feature reminiscent of snoRNA host transcripts 29 , 30 ( Figures 6D and S5E ). The UCE region in particular appeared to resemble a C/D box snoRNA, with sequences matching potential C box (AUGAUGA) and D box (CUGA) motifs adjacent to a potential six base-pair terminal stem. The guide sequences of C/D box snoRNAs, which base-pair directly with pre-rRNA, are typically located ∼10-21 nucleotides upstream of the D box. Consistent with this configuration, we noted the presence of a sequence with complementarity to 32S pre-rRNA within this window upstream of the CRNDE UCE D box ( Figures 6D and S5F ). This 12-nucleotide putative guide sequence contains a single mismatch at the position at which the 2’- O -methyl modification would be installed by a canonical C/D box snoRNP. Accordingly, methylation at this position, which is located in the linker between helices H55 and H56 in 28S rRNA domain III ( Figures S6A and S6B ), has not been detected in prior studies of rRNA nucleotide modifications 65 . To determine if the UCE of CRNDE interacts with components of C/D box snoRNPs, we performed UV-crosslinking and immunoprecipitation of endogenous fibrillarin (FBL), the methyltransferase guided by C/D box snoRNAs 66 ( Figures 6E and S5G ). We observed strong enrichment of CRNDE UCE and, as expected, 32S pre-rRNA, but not control RNAs, in FBL pull-downs. The specificity of this interaction was further confirmed by reciprocal pull-down of the endogenous CRNDE UCE RNP from UV crosslinked cells under denaturing conditions using ASOs ( Figure 6F ). Both FBL and 15.5K, another C/D box snoRNP component, co-purified with CRNDE UCE , while Dyskerin (DKC1), a component of H/ACA box snoRNPs, was not detected. These data provide strong evidence that the UCE of CRNDE assembles a snoRNP-like complex. Nevertheless, we were not able to detect any evidence of processing of the UCE into a snoRNA-like small RNA. Northern blotting using a probe complementary to the UCE failed to detect any small RNA species ( Figure S5H ). Moreover, immunoprecipitation of FBL led to equal enrichment of the UCE and final exon of CRNDE ( Figure 6E ), suggesting that FBL associates with the unprocessed CRNDE UCE isoform. We next asked whether the putative guide sequence in the CRNDE UCE snoRNA-like element mediates the observed interaction with 32S pre-rRNA. The wild-type UCE-containing intron sequence (UCE wild-type), or a version with a mutation in the putative guide sequence (UCE mutant), were expressed in 786-O cells, while endogenous CRNDE was silenced using CRISPRi ( Figures 6G and S5I ). AMT crosslinking and pull-down of the CRNDE UCE using ASOs revealed the expected enrichment of 32S pre-rRNA in cells expressing the wild-type UCE intron but not in cells expressing the mutant sequence, demonstrating that this region is required for interaction with pre-rRNA ( Figures 6H and 6I ). Additionally, we observed that the UCE guide sequence mutation also abolished the ability of the UCE intron to support RCC cell growth ( Figure 6J ). In sum, these data demonstrated that the UCE of CRNDE functions as an unprocessed C/D box snoRNA-like sequence that interacts directly with 32S pre-rRNA. This interaction likely facilitates efficient loading of eIF6, which is bound to a sequence adjacent to this element, onto pre-60S subunits. DISCUSSION Many prior studies have documented a role for CRNDE in cancer cell proliferation and survival, making it one of the most highly studied lncRNAs in human malignancies 35 – 38 . Nevertheless, no consensus exists regarding the molecular function of this lncRNA that underlies its hyperactivity in cancer. Here we describe a key role for CRNDE in ribosome biogenesis and demonstrate that this function is essential for proliferation of RCC cells. These findings deepen our understanding of how noncoding RNAs govern ribosome assembly and illuminate how cancer cells can co-opt these mechanisms to fuel tumor growth. To identify lncRNAs that are essential for RCC cell proliferation and/or survival, we generated a custom CRISPRi library targeting lncRNAs that are overexpressed in RCC tumors. Screens in multiple RCC cell lines, followed by validation studies in patient-derived primary RCC cultures, revealed that CRNDE is required for growth of all tested RCC cells. Rescue experiments demonstrated that this activity is attributable to an alternatively-spliced isoform of CRNDE containing an ultraconserved element ( CRNDE UCE ). We found that this transcript localizes to the nucleolus where an unprocessed C/D box-snoRNA-like element within the UCE base-pairs with maturing rRNA precursors. CRNDE UCE also interacts directly with eIF6, a critical factor for 60S ribosomal subunit biogenesis, and promotes loading of eIF6 onto pre-60S subunits and subsequent steps in pre-60S maturation. Based on these findings, we propose that CRNDE UCE functions as a unique ribosome assembly factor that exploits both RNA:RNA and RNA:protein interactions to position eIF6 in close proximity to its binding site on the pre-60S subunit, thereby enhancing ribosomal subunit maturation ( Figure 6K ). Consistent with this model, the structure of a human nucleolar pre-60S particle containing eIF6 67 shows that the CRNDE UCE binding site in 32S pre-rRNA is on the surface of the particle in a structurally unresolved loop where it would likely be accessible for base-pairing ( Figure S6C ). This site is on the same face and within 120Å of the eIF6 binding site on the maturing ribosomal subunit, a distance that could easily be bridged by the ∼600 nucleotides separating the snoRNA-like element and the eIF6 binding site in CRNDE UCE . We posit, therefore, that base-pairing between CRNDE UCE and 32S pre-rRNA at this site facilitates recruitment of the CRNDE UCE :eIF6 complex to the pre-60S particle, although it is also possible that CRNDE UCE binding induces conformational changes in the pre-ribosomal subunit that promote eIF6 loading. A significant challenge for understanding the functions of lncRNAs is the paucity of well-established functional RNA domains, whose presence in a transcript is predictive of a specific molecular activity. Our data, together with previously reported results, demonstrate that snoRNA-like sequences are a repeatedly used class of RNA elements that impact ribosome biogenesis in multiple ways. Classically, C/D box and H/ACA box snoRNAs function as guides for 2’- O -methylation and pseudouridylation of pre-rRNA, respectively. As such, they are strongly localized to the nucleolus and evolutionarily optimized to base-pair with pre-rRNA. These attributes can be exploited for regulation of other steps in ribosome production. For example, some snoRNAs direct specific pre-rRNA processing events 29 or regulate the rate of incorporation of ribosomal proteins into maturing ribosomal subunits 68 . LncRNAs harboring partially processed or unprocessed snoRNA-like elements have been shown to regulate transcription and chemical modification of pre-rRNA 32 , 33 . Our discovery that CRNDE UCE uses an unprocessed snoRNA-like element to interact with pre-rRNA in order to deliver a key assembly factor to maturing pre-60S subunits expands the known mechanisms through which this versatile class of RNA elements can impact ribosome assembly. Moreover, these results illustrate how the presence of a snoRNA-like sequence within a lncRNA should be regarded as a strong clue that the transcript may localize to the nucleolus and regulate ribosome production. Many alternatively-spliced variants of CRNDE have been detected 35 , 54 , providing a regulatable mechanism for controlling the activity of this lncRNA. Retention of intron 3 yields the CRNDE UCE transcript containing the eIF6 binding site and the snoRNA-like element, which promote maturation of the pre-60S subunit. Splicing of this intron produces transcript variants that localize to the cytoplasm and may perform other cellular functions. Thus, signaling pathways and factors that regulate this splicing event may impact ribosome biogenesis. Notably, the location of a snoRNA sequence within its host intron is a critical determinant of the efficiency of its processing into a mature small RNA. The optimal location for an efficiently processed snoRNA is 70-80 nucleotides upstream of the 3’ splice site, while deviations from this optimum can impair snoRNA generation 69 , 70 . The snoRNA-like element in CRNDE UCE is located approximately 1 kb upstream of the nearest 3’ splice site, providing a likely explanation for its failure to be processed into a mature snoRNA. This enables the physical coupling of the snoRNA-like sequence with the eIF6 binding element, allowing CRNDE UCE to function as a bi-partite ribosome assembly factor. In addition to our finding that CRNDE is overexpressed and essential for proliferation in RCC, this lncRNA has been demonstrated to support proliferation in many types of cancer cells 37 , 38 , 55 , 71 , 72 . This suggests that CRNDE UCE may play a broad role in driving ribosome biogenesis in diverse human malignancies, although it is important to note that CRNDE has been reported to promote tumorigenesis through a variety of additional mechanisms such as modulating the activity of the Wnt/β-catenin, mitogen-activated protein kinase (MAPK), and PI3K/AKT/mTOR pathways 37 . In light of the extreme evolutionary conservation of the UCE, and our discovery of its role in ribosome biogenesis, it is surprising that complete deletion of the Crnde locus is compatible with overtly normal development in mice 73 . This suggests that, rather than functioning as a core component of the 60S biogenesis pathway, CRNDE UCE may act as an enhancer of ribosome assembly that is selectively deployed in settings of increased ribosomal demand, such as in regenerating tissues or in response to other stresses that require high levels of protein synthesis. Given that CRNDE appears to be dispensable under normal physiologic conditions, but is essential in RCC and other malignancies, targeting this lncRNA, or the pathways that regulate it, may provide a well-tolerated therapeutic strategy for cancer. Achieving this goal will require a deeper understanding of the physiologic roles of CRNDE UCE -regulated ribosome biogenesis, a priority for future study. AUTHOR CONTRIBUTIONS J-S.L., D.T., Y.C., F.R., J.B., and J.T.M. designed experiments and interpreted the results. J-S.L., D.T., and Y.C. performed experiments. He Z. performed bioinformatic analyses. F.R. and J.B. provided technical assistance and critical reagents. J-S.L. and J.T.M. wrote the manuscript. DECLARATION OF INTERESTS J.T.M is a scientific advisor for Ribometrix, Inc. and owns equity in Orbital Therapeutics, Inc. MATERIALS AND METHODS Cell culture 786-O cells were cultured in RPMI (Invitrogen) supplemented with 10% fetal bovine serum (Sigma-Aldrich) and 1X Antibiotic-Antimycotic (Gibco). A-498 and ACHN cells were cultured in Minimum Essential Medium Eagle (Sigma-Aldrich) supplemented with 10% fetal bovine serum and 1X Antibiotic-Antimycotic. Primary patient-derived RCC cells were cultured in Minimum Essential Medium (Gibco) supplemented with 1X MEM non-essential amino acids (Gibco), Hydrocortisone (0.4 mg/mL, StemCellTechnologies), EGF (5 µg/mL, Gibco), 10% fetal bovine serum, and 1X Antibiotic-Antimycotic. HEK293T and HeLa cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum and 1X Antibiotic-Antimycotic. BJ cells were cultured in DMEM supplemented with 20% Medium 199 (Gibco), 10% fetal bovine serum, and 1X Antibiotic-Antimycotic. 786-O, A-498, ACHN, HEK293T, and HeLa cells were obtained from ATCC. Primary patient-derived RCC cells were previously described 44 . Cell lines were confirmed to be free of mycoplasma contamination. Generation of CRISPRi cell lines RCC cell lines (786-O, A-498 and ACHN), HeLa cells, and BJ cells were infected with a dCas9 KRAB -mCherry lentivirus (Addgene #60954) 77 and clonal lines stably expressing high levels of mCherry were established by single-cell sorting and expansion. Primary patient-derived RCC CRISPRi cells (XP127 and XP165) were generated by infecting with dCas9 KRAB -mCherry lentivirus and sorting the cells with high mCherry expression (top 30%). sgRNA library design The UT Southwestern (UTSW) Kidney Cancer Program (KCP) platform was used to analyze primary patient RNA-seq data from 48 RCC tumors and their matched normal kidney samples obtained from UTSW-affiliated hospitals, including Parkland Hospital and Children’s Medical Center 44 , 78 . Of a total of 63,677 expressed transcripts in this dataset, 13,283 were assigned a noncoding RNA biotype (antisense, sense intronic, sense overlapping, TEC, and lincRNA). Transcripts with these biotypes that exhibited >2-fold upregulation in tumor samples compared to matched normal pairs, an expression value of 21 TPM in tumors, detectable expression in CCLE kidney cancer cell lines (786-O, A-498, Caki-2, and ACHN), and overexpression in TCGA RCC data were selected for sgRNA design (572 genes). Additionally, the 181 most highly expressed lncRNAs in UTSW RCC tumors that were not already selected were included. This yielded a final set of 753 candidate lncRNAs. sgRNAs were designed using a previously-described algorithm that incorporates information on chromatin state, guide position relative to transcription start site (TSS), predicted off-target sites, and other sequence features 79 . 10 sgRNAs per TSS were designed. 450 previously-designed non-targeting controls 80 and 120 previously-designed depletion controls targeting common essential genes (PCNA, RPA1, RPA3, RPS15A, RPS19, RPS11, RPS21, RPL32, RPS18, RPL7A, RPL8, RPL6) 79 were included in the library, producing a final library size of 11,814 sgRNAs. Oligonucleotides were synthesized by CustomArray and shotgun cloned into pU6-sgRNA lentiviral vector (Addgene #60955) as previously described 77 . Noncoding RNA targets and sequences of sgRNAs are provided in Table S1 . CRISPRi screens in RCC cells CRISPRi screens were performed in replicate using two independent dCas9 KRAB expressing clones per cell line. For each replicate, 5 × 10 7 cells were seeded into fourteen 15 cm dishes, with each dish containing medium supplemented with 6 µg/mL of polybrene (Millipore) and the lentiviral library at a multiplicity of infection of ∼0.3. After overnight incubation, media was changed and cells were cultured for 2 days, followed by selection in 2 µg/mL puromycin for 3 days. Following selection, at least 1.2 × 10 7 cells were plated for each replicate, representing ∼1000x coverage of the library. This timepoint was designated “day 0”. Cells were maintained in 1 µg/mL puromycin for 15 days, with passaging every 3 days, each time plating at least 1.2 × 10 7 cells to maintain a minimum of 1000x library coverage. Cells were harvested at day 0 and day 15 for genomic DNA isolation. Genomic DNA was extracted using the MasterPure Complete DNA Purification kit (Lucigen). Sequencing libraries were generated through two sequential rounds of PCR using Herculase II Fusion DNA polymerase (Agilent). For the first round of PCR, 6.6 µg of genomic DNA (representing ∼10 6 cells) was used in each 100 µL reaction. A total of 12 first-round PCR reactions were performed per replicate, with 18 cycles of amplification (all primer sequences provided in Table S3 ). All first-round PCR reactions from each replicate were then pooled. For the second round of PCR, 5 µL of the pooled first-round PCR product and primers containing barcodes and Illumina sequencing adaptors were used, with 6 to 8 cycles of amplification. PCR products were purified using Agencourt AMPure XP beads (Beckman Coulter Life Sciences). The amplicons were sequenced on an Illumina NextSeq500 with 75 bp single-end reads. sgRNA sequences were extracted from fastq files using an in-house Galaxy script, and normalized read counts were calculated. MAGeCK analysis 48 was performed to identify genes targeted by depleted sgRNAs at day 15 compared to day 0. CRISPRi-mediated gene knockdown Individual sgRNAs were cloned into pU6-sgRNA lentiviral vector (Addgene #60955) as previously described 77 (sequences provided in Table S3) . CRISPRi cells were transduced with lentiviral vectors in medium containing 6 µg/mL of polybrene (Millipore). After transduction, cells were cultured for 2 days, followed by selection in 2 µg/mL puromycin for 3 days prior to analysis. For CRNDE knockdown experiments, CRNDE sg1 was used unless otherwise specified, due to its superior knockdown efficiency compared to CRNDE sg2. Cell proliferation assay Cells were seeded at a density of 2 ×10 5 cells per well in 6-well plates in 2 mL of media. Cells were passaged every 3 days and re-seeded at a density of 2 ×10 5 cells per well after each passage. A Countess cell counter (Thermo Fisher Scientific) was used to quantify cells at each passage, and cumulative cell numbers were plotted. All growth curve experiments were performed with 3 biological replicates. RNA isolation and qRT-PCR Total RNA was extracted from cells using the QIAGEN miRNeasy Mini kit with on-column DNase digestion. cDNA was synthesized from 1 µg of total RNA using the Primescript RT Master Mix (Takara) according to the manufacturer’s instructions. SYBR Green PCR master Mix (Applied Biosystems) was used for qPCR reactions. RNA expression levels were normalized to GAPDH using the ΔΔCt method. Primer sequences used for qRT-PCR are provided in Table S3 . Oligo(dT)-primed RT-PCR To detect CRNDE splicing variants by RT-PCR, oligo(dT)-primed reverse transcription was performed using SuperScript IV Reverse Transcriptase (Thermo Fisher Scientific). In brief, 500 ng of total RNA was mixed with 1 μL of 50 μM oligo(dT)20 primer and 1 μL of 10 mM dNTP mix, in a total volume of 13 μL. The mixture was heated at 65°C for 5 minutes and then chilled on ice for 1 minute. For the RT reaction, 4 μL of 5x SSIV buffer, 1 μL of 100 mM DTT, 1 μL of RNase Inhibitor, and 1 μL of SuperScript IV enzyme were added to the annealed RNA mixture. The final reaction was incubated at 50°C for 30 minutes, followed by enzyme inactivation at 80°C for 10 minutes before using cDNA for subsequent PCR reactions. Primer sequences used for RT-PCR are provided in Table S3 . EdU incorporation assay EdU incorporation assays were performed using the Click-iT Plus EdU Alexa Fluor 488 Imaging Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. 786-O cells were seeded in 4-well Nunc Lab-Tek II chamber slides (50,000 cells/well, Thermo Fisher Scientific) and cultured for 24 hours. Half of the medium was then replaced with fresh medium containing 20 μM EdU, and cells were incubated for 3 hours. Cells were then fixed with 3.7% formaldehyde and permeabilized with 0.5% Triton X-100. Deoxyuridine incorporation was detected using Click-iT chemistry according to the manufacturer’s instructions. DAPI (2.5 µg/mL) was used for nuclear staining. Cells were imaged using a Zeiss LSM980 confocal microscope. Each experiment was conducted three times, with approximately 200 cells counted per replicate. Images were analyzed using Fiji (ImageJ v1.52p). Western blotting Cells were lysed in 2× NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) for 5 minutes at 95°C. Proteins were separated on 4-12% Bis-Tris NuPAGE gels (Thermo Fisher Scientific) and wet transferred onto nitrocellulose membranes (0.45 μm, Cytiva). Blocking was performed in TBST containing 5% non-fat milk for 1 hour at room temperature. Membranes were incubated with primary antibodies overnight at 4°C, followed by incubation with IR dye-labeled secondary antibodies for 1 hour at RT. Blots were imaged using a LICOR Odyssey imager. All antibodies are listed in Table S4 . Cloning and stable expression of rescue constructs Tet-On 3G inducible PiggyBac expression vector XLone-GFP (Addgene #96930) 51 was used for rescue experiments. Rescue constructs were cloned into this vector between the KpnI and SpeI restriction sites using NEBuilder HiFi DNA Assembly Master Mix (NEB) according to the manufacturer’s instructions. Sequences of all rescue constructs are provided in Table S3 . For constructs that contained the CRNDE sgRNA1 sequence, the PAM sequence was mutated for sgRNA resistance. Stable expression of CRNDE rescue constructs was achieved by transfecting 786-O cells with XLone- CRNDE plasmids along with a plasmid encoding the PiggyBac transposase driven by a CAG promoter, derived from pCMV-hyPBase 81 . Transfected cells were selected with 10 μg/mL blasticidin and single-cell clones were expanded. Rescue constructs were induced using 0.5 μg/mL of doxycycline (Sigma). Northern blot analysis Total RNA (20 μg) or RNA from nucleolar fractions (10 μg) was separated on 1% formaldehyde-agarose gels for larger RNA, or 6% TBE-urea polyacrylamide gels for smaller RNA, and then transferred to BrightStar-Plus nylon membranes (Thermo Fisher Scientific). Membranes were crosslinked using a 254 nm UV crosslinker at 120 mJ/cm 2 . CRNDE UCE probes were PCR amplified using primers specific to the UCE and radiolabeled with the Random Primed DNA Labeling Kit (Roche). Probe hybridization was performed using ULTRAhyb (Thermo Fisher Scientific) according to the manufacturer’s instructions. For pre-rRNA northern blots, ITS1 and ITS2 oligo probes were radiolabeled with T4 Polynucleotide Kinase (NEB). Probe hybridization was performed using ULTRAhyb-Oligo (Thermo Fisher Scientific) buffer, following the manufacturer’s instructions. Primers and oligo probe sequences are provided in Table S3 . Measurement of CRNDE UCE copy number The UCE-containing intron of CRNDE was in vitro transcribed using the HiScribe T7 High Yield RNA Synthesis Kit (NEB) and used to generate a standard curve with defined numbers of CRNDE UCE copies. For each cell line, total RNA was extracted from 1 × 10 6 cells and reverse transcribed into cDNA for qPCR analysis along with the in vitro transcribed RNA to determine copy number. Subcellular fractionation Fractionation of cytoplasm and nuclei was performed as described previously 82 , 83 . Briefly, cells were harvested by trypsinization and lysed in 250 µL cytoplasmic lysis buffer (10 mM HEPES pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 0.34M sucrose, 0.1% Triton X-100) supplemented with 100 U SUPERase·In RNase Inhibitor (Thermo Fisher Scientific). Following a 10 minutes incubation on ice, the sample was centrifuged at 1300 g for 5 minutes at 4°C. The supernatant, representing the cytoplasmic fraction, was collected and centrifuged at 16,000 g for 15 minutes at 4°C to clear debris. The initial pellet, representing the nuclear fraction, was washed in cytoplasmic lysis buffer to remove residual cytoplasm. The pellet was then resuspended in 250 µL nuclear lysis buffer [50 mM Tris-HCl pH 8, 500 mM NaCl, 1.5 mM MgCl 2 , 0.5% NP-40, and 100 U SUPERase·In RNase Inhibitor (Thermo Fisher Scientific)]. RNA was extracted from each of these fractions using the miRNeasy Mini Kit (Qiagen) with on-column DNase digestion, following the manufacturer’s instructions. Primer sequences used for qRT-PCR are provided in Table S3 . Pre-ribosome sequential extraction Pre-ribosome sequential extraction (PSE) was performed as described previously 56 . 7 × 10 6 cells were pelleted and resuspended in 0.5 mL of SN1 buffer (20 mM HEPES pH 7.5, 130 mM KCl, 10 mM MgCl₂, 0.05% Igepal CA-630) supplemented with 1x complete protease inhibitor cocktail (Roche) and 600 U/mL RNasin (Promega). The suspension was centrifuged at 1300 × g for 4 minutes at 4°C. The resulting supernatant was collected and stored as the SN1 fraction. The pellet was washed with 0.5 mL of SN1 buffer, then resuspended in 0.3 mL of SN2 buffer (10 mM HEPES pH 7.5, 10 mM NaCl, 5 mM MgCl₂, 0.1% Igepal CA-630, 0.5 mg/mL heparin,) supplemented with 600 U/mL RNasin (Promega) and 50 U TURBO DNase (Thermo Fisher Scientific). The mixture was incubated for 10 minutes at room temperature with gentle mixing. The lysate was then centrifuged at 12,300 × g for 10 minutes at 4°C, and the supernatant was collected as the SN2 fraction. The remaining pellet was resuspended in 0.4 mL of SN3 buffer [20 mM HEPES pH 7.5, 200 mM NaCl, 4 mM EDTA, 0.1% Igepal CA-630, 0.04% sodium deoxycholate, 4 mM imidazole, 0.1 mg/mL heparin, 1 mM DTT, 1x complete protease inhibitor cocktail (Roche), 600 U/mL RNasin (Promega)]. This mixture was incubated for 20 minutes at room temperature with gentle rotation. The extract was centrifuged at 12,300 × g for 10 minutes at 4°C, and the supernatant was collected as the SN3 fraction. For western blotting, samples from equal cell equivalents of the SN1, SN2, and SN3 fractions (in a volumetric ratio of 10:6:8) were mixed with 2× NuPAGE LDS Sample Buffer (Thermo Fisher Scientific). RNA was extracted from each fraction using the RNeasy Mini Kit (Qiagen). All antibodies are listed in Table S4 . Primer sequences used for qRT-PCR are provided in Table S3 . RNA fluorescence in situ hybridization (RNA FISH) RNA FISH was performed as previously described 84 , 85 . Briefly, DIG-labeled anti-sense RNA probes for CRNDE UCE were synthesized by in vitro transcription using a DIG-labeling mix (Roche) and purified using Micro Bio-Spin P-30 chromatography columns (Bio-Rad). Primers used for amplification of DNA template are provided in Table S3 . 786-O cells (5 × 10 4 ) were seeded in 4-well Nunc Lab-Tek II chamber slides (Thermo Fisher Scientific) and cultured for 2 days. Cells were rinsed twice in DEPC-treated phosphate buffered saline (PBS) and fixed in 4% paraformaldehyde for 10 minutes at room temperature. Cells were then washed once with DEPC-treated PBS and permeabilized with 0.5% Triton X-100 for 10 minutes at room temperature. After permeabilization, cells were washed twice with DEPC-treated PBS and incubated with pre-hybridization buffer (50% formamide, 2X SSC, 1X Denhardt’s solution, 10 mM EDTA, 0.1 mg/mL yeast tRNA, 0.01% Tween-20) for 1 hour. DIG-labelled RNA probes (10 ng/μL) were diluted in hybridization buffer (prehybridization buffer with 5% dextran sulfate), denatured at 75 °C for 10 minutes, and hybridized at 55 °C for 18 hours. Following hybridization, samples were washed, treated with RNase A, and blocked for 1 hour at room temperature with blocking reagent (Roche). Detection of DIG-labeled probes were performed by incubation with a mouse monoclonal anti-DIG primary antibody (Roche), followed by incubation with Cy3-labeled goat anti-mouse IgG secondary antibody (EMD Millipore). Nuclei were stained with DAPI (2.5 µg/mL) for 1 minute, washed with TBST, and coverslips were mounted with SlowFade Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific). Images were acquired using a Zeiss LSM980 confocal microscope with a 63x oil objective. Images were analyzed using Fiji (ImageJ v1.52p). Sucrose gradient ultracentrifugation and fractionation Polysome fractionation by sucrose gradient ultracentrifugation was performed as described 86 with minor modifications to the protocol. Cells were incubated with 100 µg/mL cycloheximide (Sigma) in growth medium for 10 minutes, then washed twice with ice-cold 1x PBS containing 100 µg/mL cycloheximide. Cells were scraped in 5 mL of ice-cold 1x PBS containing 100 µg/mL cycloheximide and collected by centrifugation. Cell pellets were lysed in 500 µL hypotonic buffer (5 mM Tris-HCl pH 7.5, 2.5 mM MgCl 2 , 1.5 mM KCl, 100 µg/mL cycloheximide, 2 mM DTT, 0.5% Triton X-100, and 0.5% sodium deoxycholate) supplemented with 1x EDTA-free protease inhibitor cocktail (Roche) and 200 U/mL RNasin (Promega). Lysates were centrifuged at 16,000 x g for 7 minutes at 4° C. Supernatants were collected, diluted with lysis buffer as needed so all samples had an equivalent OD 260 . The samples were then loaded onto a 5–50% sucrose gradient. Gradients were ultracentrifuged at 36,000 rpm for 2 hours at 4°C using a TH-641 rotor (Thermo Fisher Scientific) and fractionated on a Piston Fractionator (BioComp). RNA antisense purification and mass spectrometry (RAP-MS) RAP-MS coupled with organic phase separation was performed as previously described 58 , 60 with the following modifications: 1. UV crosslinking 786-O cells were grown to approximately 80-90% confluence in 15 cm dishes. The cells were washed twice with ice-cold PBS and 6 mL ice-cold PBS was added to each plate. Crosslinking was performed at 254 nm UV with an energy setting of 400 mJ/cm² using a Spectrolinker XL-1500 (Spectronics). The cells were then scraped and pelleted by centrifugation at 1000 x g for 5 minutes. 2. Organic Phase Separation 20 million cells were lysed in 900 µL of total cell lysis buffer [10 mM Tris-HCl pH 7.5, 500 mM LiCl, 0.5% Triton X-100, 0.2% SDS, 0.1% sodium deoxycholate, 400 U SUPERase·In RNase Inhibitor (Thermo Fisher Scientific), 1x EDTA-free protease inhibitor cocktail (Roche)]. Samples were incubated on ice for 10 minutes, during which the cell lysate was passed 3-5 times through a 26-gauge needle attached to a 1 mL syringe. The samples were then sonicated using a Bioruptor Plus (30 seconds on/30 seconds off, 5 cycles). Lysates were treated with 20 U TURBO DNase (Thermo Fisher Scientific) for 30 minutes at 37°C. Each sample was split into 4 tubes and 750 µL TRIzol LS was added to 250 µL of lysate, followed by the addition of 200 µL of chloroform per 1 mL of TRIzol mix. Samples were centrifugated at 20,000 x g for 15 minutes. The aqueous phase was removed, and the interphases from each sample were collected in a 2 mL tube. The interphase was gently washed twice with 1 mL of low SDS buffer (50 mM Tris-HCl, 1 mM EDTA, 0.1% SDS) by centrifugation at 5000 g for 2 minutes at room temperature, and the supernatant was discarded. After washing, the flakes were disintegrated by pipetting into 100 µL of low SDS buffer and 900 µL of ethanol. The samples were incubated at -20°C for at least 2 hours. The samples were then centrifuged at 20,000 x g for 30 minutes at 4°C and the pellet was washed with 70% ethanol. The pellet was then resuspended in 500 µL of high SDS buffer (20 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.4% SDS) and incubated for 20 minutes at 56°C. The samples were then centrifuged at 1000 x g for 2 minutes to separate the soluble from the insoluble material. The supernatant was collected and the volume was adjusted to 1 mL using concentrated RAP-MS hybridization buffer (final concentrations: 10 mM Tris-HCl pH 7.5, 500 mM LiCl, 5 mM EDTA, 0.2% SDS, 0.5% DDM, 4 M urea, 2.5 mM TCEP) with 400 U SUPERase·In RNase Inhibitor (Thermo Fisher Scientific) and 1x EDTA-free protease inhibitor cocktail (Roche). 3. RAP-MS To pull-down CRNDE UCE , 60-nucleotide 5’ biotinylated ASOs (IDT) were used. 200 pmol ASOs per 20 million cells were prepared by heating ASOs at 85°C for 3 minutes, mixing with streptavidin magnetic beads (NEB), incubating for 1 hour at room temperature, and then adding to 1 mL sample in hybridization buffer prepared in step 2. Hybridization was carried out at 60°C for 2 hours. Post-hybridization, the beads were washed, and elution was performed with water at 70°C for 5 minutes. Label-free semi-quantitative mass spectrometry was performed at the UT Southwestern Proteomics Core using reverse-phase LC-MS/MS and an Orbitrap Fusion Lumos mass spectrometer. Raw MS data files were analyzed using Proteome Discoverer v2.4 SP1 (Thermo Fisher Scientific), with peptide identification performed using Sequest HT searching against the human protein database from UniProt. To directly detect protein interactors by western blotting, proteins were eluted from streptavidin-coated magnetic beads after the final wash by resuspending beads in NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) and incubating for 10 minutes at 70° C. Eluted proteins were detected by western blotting as described above. All antibodies are listed in Table S4 . UV crosslinking and RNA immunoprecipitation (UV-RIP) UV-RIP was performed as previously described with the following modifications 85 . 786-O cells (1.5 × 10 7 ) were washed with ice-cold PBS and UV crosslinked on ice at 254 nm with 400 mJ/cm² using a Spectrolinker XL-1500 (Spectronics). Cells were scraped in cold PBS and pelleted by centrifugation. Cell pellets were lysed in 1 mL of cold lysis buffer [50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 1x complete protease inhibitor cocktail (Roche), 400 U/mL RNasin (Promega)] for 30 minutes on ice followed by sonication using a Bioruptor Plus (15 seconds on/60 seconds off, 5 cycles). Lysates were cleared by centrifugation at 16,000 x g for 15 minutes at 4°C. 50 µL (1.5 mg) of pre-washed Protein G Dynabeads (Thermo Fisher Scientific) coupled with 5 ug of antibody was added to the cleared lysate and rotated for 2 hours at 4° C. Beads were washed three times with 900 µL cold High Salt Wash Buffer (50 mM Tris-HCl pH 7.5, 1M NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate) and then washed three times with 500 µL wash buffer (20 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 0.2% Tween-20). After the final wash, each sample was resuspended in 100 µL of wash buffer. 30 µL of the sample was used for western blotting. The remainder was treated with proteinase K (NEB) followed by RNA extraction with TRIzol. Expression and purification of eIF6-3XFlag eIF6-3XFlag was cloned into pLenti-CMV-Blast (Addgene #17486) 87 using the Esp3I and BamH1 restriction sites. After transducing HEK293T cells with this lentiviral construct, cells were cultured for 2 days, followed by selection in 10 µg/mL blasticidin for 10 days. HEK293T eIF6-3XFlag cells (1 × 10 7 cells) were harvested and resuspended in 500 µL of lysis buffer [50 mM Tris-HCl pH 7.5, 300 mM NaCl, 0.5% NP-40, 0.1% sodium deoxycholate, 5 mM MgCl 2 , 2 mM DTT, 1x complete protease inhibitor cocktail (Roche)] for 30 minutes on ice, followed by sonication using a Bioruptor Plus (15 seconds on/60 seconds off, 3 cycles). An equal volume of dilution buffer [50 mM Tris-HCl pH 7.5, 0.5% NP-40, 2 mM DTT, 1x complete protease inhibitor cocktail (Roche)] was then added. The samples were cleared by spinning at 16,000 x g for 15 minutes. 25 µL of anti-Flag magnetic beads (Thermo Fisher Scientific) were added per approximately 1 mg of total protein in the lysate, and the samples were incubated at 4°C for 4 hours. The beads were washed four times for 5 minutes each with wash buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl, 0.05% sodium deoxycholate, 0.5% NP-40). eIF6 was eluted from the beads in 100 µL of elution buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.05% NP-40, 10% glycerol, 1× EDTA-free Protease Inhibitor Cocktail, 1.5 mg/mL 3×Flag peptide) at 16°C for 30 minutes at 800 rpm. The elution step was repeated and eluates were combined. Electrophoretic mobility shift assay (EMSA) EMSAs were performed using purified eIF6-3XFlag protein and RNA synthesized by in vitro transcription with the HiScribe T7 High Yield RNA Synthesis Kit (NEB). Primers used for amplification of UCE intron or UCE intron fragment templates are provided in Table S3 . In vitro transcribed RNAs were folded by heating at 65°C for 5 minutes, then slowly cooled down to room temperature. Protein-RNA binding was carried out with purified eIF6-3XFlag (200 nM) and folded RNA (0.5 pmol) in binding buffer (10 mM HEPES pH 7.5, 3 mM MgCl 2 , 40 mM KCl, 5% glycerol, and 1 mM DTT). After incubation at room temperature for 30 minutes, samples were immediately loaded onto a 1.2% agarose gel and electrophoresis was carried out as previously described 88 . RNAs were detected using 2x SYBR Gold (Thermo Fisher Scientific) staining. Immunolocalization of eIF6 786-O cells (5 × 10 4 ) were seeded in 4-well Nunc Lab-Tek II chamber slides (Thermo Fisher Scientific) and cultured for 2 days. Cells were rinsed twice with PBS and fixed with 4% paraformaldehyde for 15 minutes at room temperature. Cells were then washed twice with PBS. Permeabilization was performed with 0.5% Triton X-100 in PBS for 10 minutes at room temperature, followed by two washes with PBS. Samples were washed with 1X PBST (PBS + 0.1% Tween 20) for 5 minutes. Blocking was performed with 3% BSA in PBST for 30 minutes at room temperature. After blocking, samples were incubated with primary anti-eIF6 antibody diluted 1:100 in 1% BSA in PBST overnight at 4°C. Samples were then washed three times with 1X PBST. Secondary antibody incubation was performed with goat anti-mouse IgG cross-adsorbed secondary antibody (Thermo Fisher Scientific) diluted 1:200 in 1% BSA in PBST for 1 hour at room temperature, followed by three washes with PBS. Nuclei were stained with DAPI (2.5 µg/mL) for 1 minute, washed with PBS, and then coverslips were mounted with Immumount (Thermo Fisher Scientific). Images were acquired using a Zeiss LSM980 confocal microscope with a 63x oil objective. Images were analyzed using Fiji (ImageJ v1.52p). Sucrose gradient fractionation of pre-ribosomes Pre-ribosomes were analyzed by sucrose gradient ultracentrifugation as described previously 56 . Freshly prepared 400 µL samples of SN3 fraction were loaded onto a 7–50% sucrose gradient. The gradients were prepared in a buffer containing 20 mM HEPES pH 7.5, 200 mM NaCl, 4 mM EDTA, 0.1 mg/mL heparin, and 1 mM DTT. Ultracentrifugation was performed at 39,000 rpm for 165 minutes at 4°C using a TH-641 rotor (Thermo Fisher Scientific). The samples were then fractionated using a Piston Fractionator (BioComp) to evaluate pre-ribosome profiles. To detect eIF6 distribution, 0.5 mL fractions were collected from the gradient. From each fraction, 380 µL was transferred to a corresponding tube containing 130 µL of 50% trichloroacetic acid (TCA). The samples were mixed thoroughly and stored at -20°C overnight to precipitate the proteins. The proteins in each sample were pelleted by centrifugation at 16,000 x g for 15 minutes at 4°C. The pellets were then washed twice with 200 µL of 100% acetone and dried using a speed vacuum apparatus for 10 minutes. Each pellet was resuspended in 30 µL of 2x LDS Sample Buffer and neutralized with 15 µL of 2 M Tris-HCl pH 8 for western blot analysis. Co-immunoprecipitation 786-O cells (5 × 10 6 ) were harvested and lysed in 500 μL IP buffer [20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1x complete protease inhibitor cocktail (Roche)] for 30 minutes on ice, followed by sonication using a Bioruptor Plus (10 seconds on/60 seconds off, 3 cycles). Lysates were centrifuged at 16,000 x g for 15 minutes, and supernatant was collected. The cleared lysates were incubated with 2 μg anti-eIF6 or anti-NMD3 antibodies overnight at 4°C with rotation. Then, 30 μL Protein G Dynabeads (Thermo Fisher Scientific) were added to the mixture and incubated for 2 hours at 4°C, followed by washing four times with IP buffer. To elute the protein complex, 2x NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) was added to the samples, which were then boiled for 5 minutes. The eluted proteins were analyzed by western blotting. All antibodies are listed in Table S4 . RPL23a-SNAP labeling RPL23a-SNAP sequences (IDT) were cloned into a previously generated AAVS1 donor plasmid 85 using the XhoI and MfeI restriction sites. The AAVS1 / RPL23a-SNAP knock-in construct was then inserted into the AAVS1 locus of 786-O CRISPRi cells, as previously described 85 , 89 . Transfected cells were selected with 500 µg/mL G418 for at least 10 days before introducing sgRNAs for CRISPRi-mediated knockdown. Detection of newly-synthesized RPL23a using SNAP staining was performed as previously described with minor modifications 90 , 62 . Cells were incubated with SNAP-Cell Block (NEB) at a final concentration of 10 µM in growth medium at 37°C for 30 minutes to quench pre-existing ribosomes. Cells were then washed three times with fresh medium, followed by a 6-8 hour incubation in fresh medium. Cells were then incubated with 2 µM SNAP-Cell Oregon Green (NEB) for 20 minutes at 37°C to label newly synthesized RPL23a. Images were acquired using a Zeiss LSM980 confocal microscope with a 40x objective. Images were analyzed using Fiji (ImageJ v1.52p). Detection of RNA:RNA interactions by AMT crosslinking AMT crosslinking and detection of RNA:RNA interactions were performed as previously described with modifications 64 . 786-O cells (2 × 10 7 ) were harvested and resuspended in 4 mL of ice-cold 0.5 mg/mL AMT solution (+AMT) or ice-cold PBS alone (-AMT control) and incubated on ice in the dark for 15 minutes. The samples were then transferred to pre-chilled 10-cm tissue culture dishes, placed on ice under a long-wave UV bulb (350 nm) in a Spectrolinker XL-1500 (Spectronics) approximately 4 cm from the light source, and covered with a 0.3 mm glass plate. Cells were exposed to UV light for 15 minutes (450 seconds twice), then transferred to pre-chilled tubes and spun at 1000 x g for 5 minutes. The cell pellets were resuspended in 500 µL of cell lysis buffer (10 mM Tris-HCl pH 7.5, 500 mM LiCl, 0.5% Triton X-100, 0.2% SDS, 0.1% sodium deoxycholate) containing 200 U SUPERase·In RNase Inhibitor (Thermo Fisher Scientific). Lysates were treated with 20 U TURBO DNase (Thermo Fisher Scientific) for 15 minutes at 37°C, followed by treatment with 0.25 mg/mL proteinase K (NEB) for 30 minutes at 37°C. RNA was extracted using the RNeasy Mini Kit (Qiagen). Input RNA (2 µg) and biotinylated ASO probe (50 pmol) were denatured separately in 5 µL water at 85°C for 3 minutes, then mixed in 300 µL of LiCl Hybridization Buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 500 mM LiCl, 1% Triton X-100, 0.2% SDS, 0.1% sodium deoxycholate, 4 M urea) preheated to 55°C. The hybridization reaction was incubated for three hours at 55°C with shaking at 1,000 rpm. 50 µL streptavidin C1 magnetic beads (Thermo Fisher Scientific) were added and reactions were incubated at 37°C for 45 minutes to capture the complexes. The beads were washed three times with 250 µL of Low Stringency Wash Buffer (1× SSPE, 0.1% SDS, 1% NP-40, 4 M urea) and three times with 250 µL of High Stringency Wash Buffer (0.1× SSPE, 0.1% SDS, 1% NP-40, 4 M urea), each wash for 5 minutes at 60°C. RNA was eluted using RNase H, purified using TRIzol and RNA Clean & Concentrator-5 columns (Zymo Research), and then subjected to qRT-PCR as described above. Primer sequences used for qRT-PCR provided in Table S3 . Quantification and statistical analysis All experiments were repeated with a minimum of three independent biological replicates as indicated in each figure legend. All values are reported as mean ± SD in each figure. Statistical significance was analyzed using Prism 10 (GraphPad Software). Statistical analysis of CRISPRi screen was performed using MAGeCK 48 . ACKNOWLEDGEMENTS We thank the patients who provided tumors analyzed in this study. We also acknowledge Eric Campeau, Nancy Craig, Paul Kaufman, Xiaojun Lian, Didier Trono, Rudolf Jaenisch, Jonathan Weissman, and Feng Zhang for plasmids; Vanessa Schmid in the McDermott Center Next Generation Sequencing Core for assistance with high-throughput sequencing; Andrew Lemoff in the UTSW Proteomics Core for assistance with mass spectrometry; Salman Banani for assistance with CRISPRi library design; Jan Erzberger for assistance with structural analyses of rRNA and ribosomes; and Michael Buszczak, Jan Erzberger, and members of the Mendell laboratory for helpful suggestions on the manuscript. This study utilized data generated by the TCGA Research Network: https://www.cancer.gov/tcga . This work was supported by grants from CPRIT (RP220309 to J.T.M.), the Welch Foundation (I-1961 to J.T.M.), DOD (W81XWH2110815 to J-S.L.), and NIH (R01CA282036 to J.T.M. and P50CA196516 to J.B.). J.T.M. is an Investigator of the Howard Hughes Medical Institute. REFERENCES 1. ↵ Robichaud , N. , Sonenberg , N. , Ruggero , D. , and Schneider , R.J . ( 2019 ). Translational Control in Cancer . Cold Spring Harb Perspect Biol 11 , a032896 . doi: 10.1101/cshperspect.a032896 . OpenUrl Abstract / FREE Full Text 2. ↵ Pelletier , J. , Thomas , G. , and Volarevic , S . ( 2018 ). Ribosome biogenesis in cancer: new players and therapeutic avenues . Nat Rev Cancer 18 , 51 – 63 . doi: 10.1038/nrc.2017.104 . OpenUrl CrossRef PubMed 3. ↵ Elhamamsy , A.R. , Metge , B.J. , Alsheikh , H.A. , Shevde , L.A. , and Samant , R.S . ( 2022 ). Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance . Cancer Res 82 , 2344 – 2353 . doi: 10.1158/0008-5472.CAN-21-4087 . OpenUrl CrossRef 4. ↵ 4. van Riggelen , J. , Yetil , A. , and Felsher , D.W. ( 2010 ). MYC as a regulator of ribosome biogenesis and protein synthesis . Nat Rev Cancer 10 , 301 – 309 . doi: 10.1038/nrc2819 . OpenUrl CrossRef PubMed Web of Science 5. ↵ Iadevaia , V. , Liu , R. , and Proud , C.G . ( 2014 ). mTORC1 signaling controls multiple steps in ribosome biogenesis . Semin Cell Dev Biol 36 , 113 – 120 . doi: 10.1016/j.semcdb.2014.08.004 . OpenUrl CrossRef PubMed 6. ↵ Cairns , P . ( 2010 ). Renal cell carcinoma . Cancer Biomark 9 , 461 – 473 . doi: 10.3233/CBM-2011-0176 . OpenUrl CrossRef PubMed 7. ↵ Clark , D.J. , Dhanasekaran , S.M. , Petralia , F. , Pan , J. , Song , X. , Hu , Y. , da Veiga Leprevost , F. , Reva , B. , Lih , T.M. , Chang , H.Y. , et al. ( 2019 ). Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma . Cell 179 , 964 – 983 . doi: 10.1016/j.cell.2019.10.007 . OpenUrl CrossRef PubMed 8. ↵ Montanaro , L. , Trere , D. , and Derenzini , M . ( 2008 ). Nucleolus, ribosomes, and cancer . Am J Pathol 173 , 301 – 310 . doi: 10.2353/ajpath.2008.070752 . OpenUrl CrossRef PubMed Web of Science 9. ↵ Ruggero , D . ( 2012 ). Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling . Sci Signal 5 , p e38 . doi: 10.1126/scisignal.2003477 . OpenUrl Abstract / FREE Full Text 10. ↵ Delahunt , B. , Eble , J.N. , Egevad , L. , and Samaratunga , H . ( 2019 ). Grading of renal cell carcinoma . Histopathology 74 , 4 – 17 . doi: 10.1111/his.13735 . OpenUrl CrossRef PubMed 11. ↵ Bassler , J. , and Hurt , E . ( 2019 ). Eukaryotic Ribosome Assembly . Annu Rev Biochem 88 , 281 – 306 . doi: 10.1146/annurev-biochem-013118-110817 . OpenUrl CrossRef PubMed 12. ↵ 12. de la Cruz , J. , Karbstein , K. , and Woolford , J.L. , Jr. ( 2015 ). Functions of ribosomal proteins in assembly of eukaryotic ribosomes in vivo . Annu Rev Biochem 84 , 93 – 129 . doi: 10.1146/annurev-biochem-060614-033917 . OpenUrl CrossRef PubMed 13. ↵ Parker , M.D. , and Karbstein , K . ( 2023 ). Quality control ensures fidelity in ribosome assembly and cellular health . J Cell Biol 222 , e202209115 . doi: 10.1083/jcb.202209115 . OpenUrl CrossRef PubMed 14. ↵ Hurt , E. , Iwasa , J. , and Beckmann , R . ( 2024 ). SnapShot: Eukaryotic ribosome biogenesis II . Cell 187 , 1314 – 1314 . doi: 10.1016/j.cell.2024.01.043 . OpenUrl CrossRef 15. ↵ Brina , D. , Miluzio , A. , Ricciardi , S. , and Biffo , S . ( 2015 ). eIF6 anti-association activity is required for ribosome biogenesis, translational control and tumor progression . Biochim Biophys Acta 1849 , 830 – 835 . doi: 10.1016/j.bbagrm.2014.09.010 . OpenUrl CrossRef PubMed 16. ↵ Sanvito , F. , Piatti , S. , Villa , A. , Bossi , M. , Lucchini , G. , Marchisio , P.C. , and Biffo , S . ( 1999 ). The beta4 integrin interactor p27(BBP/eIF6) is an essential nuclear matrix protein involved in 60S ribosomal subunit assembly . J Cell Biol 144 , 823 – 837 . doi: 10.1083/jcb.144.5.823 . OpenUrl Abstract / FREE Full Text 17. ↵ Basu , U. , Si , K. , Warner , J.R. , and Maitra , U . ( 2001 ). The Saccharomyces cerevisiae TIF6 gene encoding translation initiation factor 6 is required for 60S ribosomal subunit biogenesis . Mol Cell Biol 21 , 1453 – 1462 . doi: 10.1128/MCB.21.5.1453-1462.2001 . OpenUrl Abstract / FREE Full Text 18. ↵ Si , K. , and Maitra , U . ( 1999 ). The Saccharomyces cerevisiae homologue of mammalian translation initiation factor 6 does not function as a translation initiation factor . Mol Cell Biol 19 , 1416 – 1426 . doi: 10.1128/MCB.19.2.1416 . OpenUrl Abstract / FREE Full Text 19. ↵ Russell , D.W. , and Spremulli , L.L . ( 1980 ). Mechanism of action of the wheat germ ribosome dissociation factor: interaction with the 60 S subunit . Arch Biochem Biophys 201 , 518 – 526 . doi: 10.1016/0003-9861(80)90540-8 . OpenUrl CrossRef PubMed Web of Science 20. Valenzuela , D.M. , Chaudhuri , A. , and Maitra , U . ( 1982 ). Eukaryotic ribosomal subunit anti-association activity of calf liver is contained in a single polypeptide chain protein of Mr = 25,500 (eukaryotic initiation factor 6) . J Biol Chem 257 , 7712 – 7719 . OpenUrl Abstract / FREE Full Text 21. ↵ Ceci , M. , Gaviraghi , C. , Gorrini , C. , Sala , L.A. , Offenhauser , N. , Marchisio , P.C. , and Biffo , S . ( 2003 ). Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly . Nature 426 , 579 – 584 . doi: 10.1038/nature02160 . OpenUrl CrossRef PubMed Web of Science 22. ↵ Senger , B. , Lafontaine , D.L. , Graindorge , J.S. , Gadal , O. , Camasses , A. , Sanni , A. , Garnier , J.M. , Breitenbach , M. , Hurt , E. , and Fasiolo , F . ( 2001 ). The nucle(ol)ar Tif6p and Efl1p are required for a late cytoplasmic step of ribosome synthesis . Mol Cell 8 , 1363 – 1373 . doi: 10.1016/s1097-2765(01)00403-8 . OpenUrl CrossRef PubMed Web of Science 23. ↵ Menne , T.F. , Goyenechea , B. , Sanchez-Puig , N. , Wong , C.C. , Tonkin , L.M. , Ancliff , P.J. , Brost , R.L. , Costanzo , M. , Boone , C. , and Warren , A.J . ( 2007 ). The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast . Nat Genet 39 , 486 – 495 . doi: 10.1038/ng1994 . OpenUrl CrossRef PubMed Web of Science 24. ↵ Weis , F. , Giudice , E. , Churcher , M. , Jin , L. , Hilcenko , C. , Wong , C.C. , Traynor , D. , Kay , R.R. , and Warren , A.J . ( 2015 ). Mechanism of eIF6 release from the nascent 60S ribosomal subunit . Nat Struct Mol Biol 22 , 914 – 919 . doi: 10.1038/nsmb.3112 . OpenUrl CrossRef PubMed 25. ↵ Huang , J.N. , and Shimamura , A . ( 2011 ). Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome . Curr Opin Hematol 18 , 30 – 35 . doi: 10.1097/MOH.0b013e32834114a5 . OpenUrl CrossRef PubMed 26. Tan , S. , Kermasson , L. , Hoslin , A. , Jaako , P. , Faille , A. , Acevedo-Arozena , A. , Lengline , E. , Ranta , D. , Poiree , M. , Fenneteau , O. , et al. ( 2019 ). EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome . Blood 134 , 277 – 290 . doi: 10.1182/blood.2018893404 . OpenUrl Abstract / FREE Full Text 27. ↵ Boocock , G.R. , Morrison , J.A. , Popovic , M. , Richards , N. , Ellis , L. , Durie , P.R. , and Rommens , J.M . ( 2003 ). Mutations in SBDS are associated with Shwachman-Diamond syndrome . Nat Genet 33 , 97 – 101 . doi: 10.1038/ng1062 . OpenUrl CrossRef PubMed Web of Science 28. ↵ Lafontaine , D.L . ( 2015 ). Noncoding RNAs in eukaryotic ribosome biogenesis and function . Nat Struct Mol Biol 22 , 11 – 19 . doi: 10.1038/nsmb.2939 . OpenUrl CrossRef PubMed 29. ↵ Ojha , S. , Malla , S. , and Lyons , S.M . ( 2020 ). snoRNPs: Functions in Ribosome Biogenesis . Biomolecules 10 , 783 . doi: 10.3390/biom10050783 . OpenUrl CrossRef 30. ↵ Kufel , J. , and Grzechnik , P . ( 2019 ). Small Nucleolar RNAs Tell a Different Tale . Trends Genet 35 , 104 – 117 . doi: 10.1016/j.tig.2018.11.005 . OpenUrl CrossRef PubMed 31. ↵ Yin , Q.F. , Yang , L. , Zhang , Y. , Xiang , J.F. , Wu , Y.W. , Carmichael , G.G. , and Chen , L.L . ( 2012 ). Long noncoding RNAs with snoRNA ends . Mol Cell 48 , 219 – 230 . doi: 10.1016/j.molcel.2012.07.033 . OpenUrl CrossRef PubMed Web of Science 32. ↵ Xing , Y.H. , Yao , R.W. , Zhang , Y. , Guo , C.J. , Jiang , S. , Xu , G. , Dong , R. , Yang , L. , and Chen , L.L . ( 2017 ). SLERT Regulates DDX21 Rings Associated with Pol I Transcription . Cell 169 , 664 – 678 . doi: 10.1016/j.cell.2017.04.011 . OpenUrl CrossRef PubMed 33. ↵ Li , D. , Zhang , J. , Wang , M. , Li , X. , Gong , H. , Tang , H. , Chen , L. , Wan , L. , and Liu , Q . ( 2018 ). Activity dependent LoNA regulates translation by coordinating rRNA transcription and methylation . Nat Commun 9 , 1726 . doi: 10.1038/s41467-018-04072-4 . OpenUrl CrossRef 34. ↵ Rinn , J.L. , and Chang , H.Y . ( 2020 ). Long Noncoding RNAs: Molecular Modalities to Organismal Functions . Annu Rev Biochem 89 , 283 – 308 . doi: 10.1146/annurev-biochem-062917-012708 . OpenUrl CrossRef PubMed 35. ↵ Graham , L.D. , Pedersen , S.K. , Brown , G.S. , Ho , T. , Kassir , Z. , Moynihan , A.T. , Vizgoft , E.K. , Dunne , R. , Pimlott , L. , Young , G.P. , et al. ( 2011 ). Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas . Genes Cancer 2 , 829 – 840 . doi: 10.1177/1947601911431081 . OpenUrl CrossRef PubMed 36. Ding , C. , Han , F. , Xiang , H. , Xia , X. , Wang , Y. , Dou , M. , Zheng , J. , Li , Y. , Xue , W. , Ding , X. , and Tian , P . ( 2018 ). LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma . J Cell Biochem 119 , 10406 – 10414 . doi: 10.1002/jcb.27389 . OpenUrl CrossRef 37. ↵ Lu , Y. , Sha , H. , Sun , X. , Zhang , Y. , Wu , Y. , Zhang , J. , Zhang , H. , Wu , J. , and Feng , J . ( 2020 ). CRNDE: an oncogenic long non-coding RNA in cancers . Cancer Cell Int 20 , 162 . doi: 10.1186/s12935-020-01246-3 . OpenUrl CrossRef 38. ↵ Shao , K. , Shi , T. , Yang , Y. , Wang , X. , Xu , D. , and Zhou , P . ( 2016 ). Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt/beta-catenin signaling in renal cell carcinoma . Tumour Biol 37 , 15997 – 16004 . doi: 10.1007/s13277-016-5440-0 . OpenUrl CrossRef 39. ↵ Barata , P.C. , and Rini , B.I . ( 2017 ). Treatment of renal cell carcinoma: Current status and future directions . CA Cancer J Clin 67 , 507 – 524 . doi: 10.3322/caac.21411 . OpenUrl CrossRef PubMed 40. ↵ Considine , B. , and Hurwitz , M.E . ( 2019 ). Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma . Curr Oncol Rep 21 , 34 . doi: 10.1007/s11912-019-0779-1 . OpenUrl CrossRef 41. ↵ Slack , F.J. , and Chinnaiyan , A.M . ( 2019 ). The Role of Non-coding RNAs in Oncology . Cell 179 , 1033 – 1055 . doi: 10.1016/j.cell.2019.10.017 . OpenUrl CrossRef PubMed 42. ↵ Durinck , S. , Stawiski , E.W. , Pavia-Jimenez , A. , Modrusan , Z. , Kapur , P. , Jaiswal , B.S. , Zhang , N. , Toffessi-Tcheuyap , V. , Nguyen , T.T. , Pahuja , K.B. , et al. ( 2015 ). Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes . Nat Genet 47 , 13 – 21 . doi: 10.1038/ng.3146 . OpenUrl CrossRef PubMed 43. Kim , K. , Zhou , Q. , Christie , A. , Stevens , C. , Ma , Y. , Onabolu , O. , Chintalapati , S. , McKenzie , T. , Tcheuyap , V.T. , Woolford , L. , et al. ( 2021 ). Determinants of renal cell carcinoma invasion and metastatic competence . Nat Commun 12 , 5760 . doi: 10.1038/s41467-021-25918-4 . OpenUrl CrossRef 44. ↵ Elias , R. , Tcheuyap , V.T. , Kaushik , A.K. , Singla , N. , Gao , M. , Reig Torras , O. , Christie , A. , Mulgaonkar , A. , Woolford , L. , Stevens , C. , et al. ( 2021 ). A renal cell carcinoma tumorgraft platform to advance precision medicine . Cell Rep 37 , 110055 . doi: 10.1016/j.celrep.2021.110055 . OpenUrl CrossRef 45. ↵ 45. Cancer Genome Atlas Research, N. , Weinstein , J.N. , Collisson , E.A. , Mills , G.B. , Shaw , K.R. , Ozenberger , B.A. , Ellrott , K. , Shmulevich , I. , Sander , C. , and Stuart , J.M. ( 2013 ). The Cancer Genome Atlas Pan-Cancer analysis project . Nat Genet 45 , 1113 – 1120 . doi: 10.1038/ng.2764 . OpenUrl CrossRef PubMed 46. ↵ Barretina , J. , Caponigro , G. , Stransky , N. , Venkatesan , K. , Margolin , A.A. , Kim , S. , Wilson , C.J. , Lehar , J. , Kryukov , G.V. , Sonkin , D. , et al. ( 2012 ). The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity . Nature 483 , 603 – 607 . doi: 10.1038/nature11003 . OpenUrl CrossRef PubMed Web of Science 47. ↵ Sinha , R. , Winer , A.G. , Chevinsky , M. , Jakubowski , C. , Chen , Y.B. , Dong , Y. , Tickoo , S.K. , Reuter , V.E. , Russo , P. , Coleman , J.A. , et al. ( 2017 ). Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection . Nat Commun 8 , 15165 . doi: 10.1038/ncomms15165 . OpenUrl CrossRef PubMed 48. ↵ Li , W. , Xu , H. , Xiao , T. , Cong , L. , Love , M.I. , Zhang , F. , Irizarry , R.A. , Liu , J.S. , Brown , M. , and Liu , X.S . ( 2014 ). MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens . Genome Biol 15 , 554 . doi: 10.1186/s13059-014-0554-4 . OpenUrl CrossRef PubMed 49. ↵ Engreitz , J.M. , Haines , J.E. , Perez , E.M. , Munson , G. , Chen , J. , Kane , M. , McDonel , P.E. , Guttman , M. , and Lander , E.S . ( 2016 ). Local regulation of gene expression by lncRNA promoters, transcription and splicing . Nature 539 , 452 – 455 . doi: 10.1038/nature20149 . OpenUrl CrossRef PubMed 50. ↵ Kopp , F. , and Mendell , J.T . ( 2018 ). Functional Classification and Experimental Dissection of Long Noncoding RNAs . Cell 172 , 393 – 407 . doi: 10.1016/j.cell.2018.01.011 . OpenUrl CrossRef PubMed 51. ↵ Randolph , L.N. , Bao , X. , Zhou , C. , and Lian , X . ( 2017 ). An all-in-one, Tet-On 3G inducible PiggyBac system for human pluripotent stem cells and derivatives . Sci Rep 7 , 1549 . doi: 10.1038/s41598-017-01684-6 . OpenUrl CrossRef PubMed 52. ↵ Hosono , Y. , Niknafs , Y.S. , Prensner , J.R. , Iyer , M.K. , Dhanasekaran , S.M. , Mehra , R. , Pitchiaya , S. , Tien , J. , Escara-Wilke , J. , Poliakov , A. , et al. ( 2017 ). Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA . Cell 171 , 1559 – 1572 . doi: 10.1016/j.cell.2017.11.040 . OpenUrl CrossRef PubMed 53. ↵ Iyer , M.K. , Niknafs , Y.S. , Malik , R. , Singhal , U. , Sahu , A. , Hosono , Y. , Barrette , T.R. , Prensner , J.R. , Evans , J.R. , Zhao , S. , et al. ( 2015 ). The landscape of long noncoding RNAs in the human transcriptome . Nat Genet 47 , 199 – 208 . doi: 10.1038/ng.3192 . OpenUrl CrossRef PubMed 54. ↵ Ellis , B.C. , Graham , L.D. , and Molloy , P.L . ( 2014 ). CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism . Biochim Biophys Acta 1843 , 372 – 386 . doi: 10.1016/j.bbamcr.2013.10.016 . OpenUrl CrossRef 55. ↵ David , A. , Zocchi , S. , Talbot , A. , Choisy , C. , Ohnona , A. , Lion , J. , Cuccuini , W. , Soulier , J. , Arnulf , B. , Bories , J.C. , et al. ( 2021 ). The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling . Leukemia 35 , 1710 – 1721 . doi: 10.1038/s41375-020-01034-y . OpenUrl CrossRef 56. ↵ Nieto , B. , Gaspar , S.G. , Sapio , R.T. , Clavain , L. , Bustelo , X.R. , Pestov , D.G. , and Dosil , M . ( 2021 ). Efficient fractionation and analysis of ribosome assembly intermediates in human cells . RNA Biol 18 , 182 – 197 . doi: 10.1080/15476286.2021.1965754 . OpenUrl CrossRef 57. ↵ Nieto , B. , Gaspar , S.G. , Moriggi , G. , Pestov , D.G. , Bustelo , X.R. , and Dosil , M . ( 2020 ). Identification of distinct maturation steps involved in human 40S ribosomal subunit biosynthesis . Nat Commun 11 , 156 . doi: 10.1038/s41467-019-13990-w . OpenUrl CrossRef 58. ↵ McHugh , C.A. , and Guttman , M . ( 2018 ). RAP-MS: A Method to Identify Proteins that Interact Directly with a Specific RNA Molecule in Cells . Methods Mol Biol 1649 , 473 – 488 . doi: 10.1007/978-1-4939-7213-5_31 . OpenUrl CrossRef 59. ↵ 59. Van Ende, R., Balzarini, S., and Geuten, K. ( 2020 ). Single and Combined Methods to Specifically or Bulk-Purify RNA-Protein Complexes . Biomolecules 10 , 1160 . doi: 10.3390/biom10081160 . OpenUrl CrossRef 60. ↵ Trendel , J. , Schwarzl , T. , Horos , R. , Prakash , A. , Bateman , A. , Hentze , M.W. , and Krijgsveld , J . ( 2019 ). The Human RNA-Binding Proteome and Its Dynamics during Translational Arrest . Cell 176 , 391 – 403 . doi: 10.1016/j.cell.2018.11.004 . OpenUrl CrossRef PubMed 61. ↵ Gantenbein , N. , Bernhart , E. , Anders , I. , Golob-Schwarzl , N. , Krassnig , S. , Wodlej , C. , Brcic , L. , Lindenmann , J. , Fink-Neuboeck , N. , Gollowitsch , F. , et al. ( 2018 ). Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression . Eur J Cancer 101 , 165 – 180 . doi: 10.1016/j.ejca.2018.07.001 . OpenUrl CrossRef PubMed 62. ↵ Ni , C. , Schmitz , D.A. , Lee , J. , Pawlowski , K. , Wu , J. , and Buszczak , M . ( 2022 ). Labeling of heterochronic ribosomes reveals C1ORF109 and SPATA5 control a late step in human ribosome assembly . Cell Rep 38 , 110597 . doi: 10.1016/j.celrep.2022.110597 . OpenUrl CrossRef PubMed 63. ↵ Cimino , G.D. , Gamper , H.B. , Isaacs , S.T. , and Hearst , J.E . ( 1985 ). Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry . Annu Rev Biochem 54 , 1151 – 1193 . doi: 10.1146/annurev.bi.54.070185.005443 . OpenUrl CrossRef PubMed Web of Science 64. ↵ Engreitz , J.M. , Sirokman , K. , McDonel , P. , Shishkin , A.A. , Surka , C. , Russell , P. , Grossman , S.R. , Chow , A.Y. , Guttman , M. , and Lander , E.S . ( 2014 ). RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites . Cell 159 , 188 – 199 . doi: 10.1016/j.cell.2014.08.018 . OpenUrl CrossRef PubMed 65. ↵ Piekna-Przybylska , D. , Decatur , W.A. , and Fournier , M.J . ( 2008 ). The 3D rRNA modification maps database: with interactive tools for ribosome analysis . Nucleic Acids Res 36 , D178 – 183 . doi: 10.1093/nar/gkm855 . OpenUrl CrossRef PubMed Web of Science 66. ↵ Massenet , S. , Bertrand , E. , and Verheggen , C . ( 2017 ). Assembly and trafficking of box C/D and H/ACA snoRNPs . RNA Biol 14 , 680 – 692 . doi: 10.1080/15476286.2016.1243646 . OpenUrl CrossRef PubMed 67. ↵ Vanden Broeck , A. , and Klinge , S. ( 2023 ). Principles of human pre-60S biogenesis . Science 381 , eadh3892 . doi: 10.1126/science.adh3892 . OpenUrl CrossRef PubMed 68. ↵ Cheng , Y. , Wang , S. , Zhang , H. , Lee , J.-S. , Ni , C. , Guo , J. , Chen , E. , Wang , S. , Acharya , A. , Chang , T.-C. , et al. ( 2024 ). A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence . Cell 187 , 1 – 20 . doi: 10.1016/j.cell.2024.06.019 . OpenUrl CrossRef 69. ↵ Hirose , T. , and Steitz , J.A . ( 2001 ). Position within the host intron is critical for efficient processing of box C/D snoRNAs in mammalian cells . Proc Natl Acad Sci U S A 98 , 12914 – 12919 . doi: 10.1073/pnas.231490998 . OpenUrl Abstract / FREE Full Text 70. ↵ Hirose , T. , Shu , M.D. , and Steitz , J.A . ( 2003 ). Splicing-dependent and -independent modes of assembly for intron-encoded box C/D snoRNPs in mammalian cells . Mol Cell 12 , 113 – 123 . doi: 10.1016/s1097-2765(03)00267-3 . OpenUrl CrossRef PubMed Web of Science 71. ↵ Ellis , B.C. , Molloy , P.L. , and Graham , L.D . ( 2012 ). CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment . Front Genet 3 , 270 . doi: 10.3389/fgene.2012.00270 . OpenUrl CrossRef 72. ↵ Ma , X. , Jin , W. , Zhao , C. , Wang , X. , and Wang , K . ( 2022 ). CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies . Mol Ther Nucleic Acids 28 , 190 – 201 . doi: 10.1016/j.omtn.2022.03.006 . OpenUrl CrossRef 73. ↵ Sauvageau , M. , Goff , L.A. , Lodato , S. , Bonev , B. , Groff , A.F. , Gerhardinger , C. , Sanchez-Gomez , D.B. , Hacisuleyman , E. , Li , E. , Spence , M. , et al. ( 2013 ). Multiple knockout mouse models reveal lincRNAs are required for life and brain development . Elife 2 , e01749 . doi: 10.7554/eLife.01749 . OpenUrl CrossRef PubMed 74. ↵ Concepcion , G.T.L. , J. A.; Wenger , A. M. ; Rowell , W. J. ( 2023 ). Reference data bundle for PacificBiosciences/HiFi-human-WGS-WDL (1.0.2) . In Zenodo, ed. 75. Tang , Z. , Kang , B. , Li , C. , Chen , T. , and Zhang , Z . ( 2019 ). GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis . Nucleic Acids Res 47 , W556 – W560 . doi: 10.1093/nar/gkz430 . OpenUrl CrossRef PubMed 76. Petrov , A.S. , Bernier , C.R. , Gulen , B. , Waterbury , C.C. , Hershkovits , E. , Hsiao , C. , Harvey , S.C. , Hud , N.V. , Fox , G.E. , Wartell , R.M. , and Williams , L.D . ( 2014 ). Secondary structures of rRNAs from all three domains of life . PLoS One 9 , e88222 . doi: 10.1371/journal.pone.0088222 . OpenUrl CrossRef PubMed 77. ↵ Gilbert , L.A. , Horlbeck , M.A. , Adamson , B. , Villalta , J.E. , Chen , Y. , Whitehead , E.H. , Guimaraes , C. , Panning , B. , Ploegh , H.L. , Bassik , M.C. , et al. ( 2014 ). Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation . Cell 159 , 647 – 661 . doi: 10.1016/j.cell.2014.09.029 . OpenUrl CrossRef PubMed Web of Science 78. ↵ Prakasam , G. , Mishra , A. , Christie , A. , Miyata , J. , Carrillo , D. , Tcheuyap , V.T. , Ye , H. , Do , Q.N. , Wang , Y. , Reig Torras , O. , et al. ( 2024 ). Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis . J Clin Invest 134 , e170559 . doi: 10.1172/JCI170559 . OpenUrl CrossRef 79. ↵ Horlbeck , M.A. , Gilbert , L.A. , Villalta , J.E. , Adamson , B. , Pak , R.A. , Chen , Y. , Fields , A.P. , Park , C.Y. , Corn , J.E. , Kampmann , M. , and Weissman , J.S . ( 2016 ). Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation . Elife 5 , e19760 . doi: 10.7554/eLife.19760 . OpenUrl CrossRef PubMed 80. ↵ Liu , S.J. , Horlbeck , M.A. , Cho , S.W. , Birk , H.S. , Malatesta , M. , He , D. , Attenello , F.J. , Villalta , J.E. , Cho , M.Y. , Chen , Y. , et al. ( 2017 ). CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells . Science 355 . doi: 10.1126/science.aah7111 . OpenUrl CrossRef PubMed 81. ↵ Yusa , K. , Zhou , L. , Li , M.A. , Bradley , A. , and Craig , N.L . ( 2011 ). A hyperactive piggyBac transposase for mammalian applications . Proc Natl Acad Sci U S A 108 , 1531 – 1536 . doi: 10.1073/pnas.1008322108 . OpenUrl Abstract / FREE Full Text 82. ↵ Lee , S. , Kopp , F. , Chang , T.C. , Sataluri , A. , Chen , B. , Sivakumar , S. , Yu , H. , Xie , Y. , and Mendell , J.T . ( 2016 ). Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins . Cell 164 , 69 – 80 . doi: 10.1016/j.cell.2015.12.017 . OpenUrl CrossRef PubMed 83. ↵ Lee , J.S. , and Mendell , J.T . ( 2020 ). Antisense-Mediated Transcript Knockdown Triggers Premature Transcription Termination . Mol Cell 77 , 1044 – 1054 . doi: 10.1016/j.molcel.2019.12.011 . OpenUrl CrossRef 84. ↵ Mito , M. , Kawaguchi , T. , Hirose , T. , and Nakagawa , S . ( 2016 ). Simultaneous multicolor detection of RNA and proteins using super-resolution microscopy . Methods 98 , 158 – 165 . doi: 10.1016/j.ymeth.2015.11.007 . OpenUrl CrossRef PubMed 85. ↵ Elguindy , M.M. , Kopp , F. , Goodarzi , M. , Rehfeld , F. , Thomas , A. , Chang , T.C. , and Mendell , J.T . ( 2019 ). PUMILIO, but not RBMX, binding is required for regulation of genomic stability by noncoding RNA NORAD . Elife 8 , e48625 . doi: 10.7554/eLife.48625 . OpenUrl CrossRef 86. ↵ Gandin , V. , Sikstrom , K. , Alain , T. , Morita , M. , McLaughlan , S. , Larsson , O. , and Topisirovic , I . ( 2014 ). Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale . J Vis Exp , 51455 . doi: 10.3791/51455 . OpenUrl CrossRef PubMed 87. ↵ Campeau , E. , Ruhl , V.E. , Rodier , F. , Smith , C.L. , Rahmberg , B.L. , Fuss , J.O. , Campisi , J. , Yaswen , P. , Cooper , P.K. , and Kaufman , P.D . ( 2009 ). A versatile viral system for expression and depletion of proteins in mammalian cells . PLoS One 4 , e6529 . doi: 10.1371/journal.pone.0006529 . OpenUrl CrossRef PubMed 88. ↵ Ream , J.A. , Lewis , L.K. , and Lewis , K.A . ( 2016 ). Rapid agarose gel electrophoretic mobility shift assay for quantitating protein: RNA interactions . Anal Biochem 511 , 36 – 41 . doi: 10.1016/j.ab.2016.07.027 . OpenUrl CrossRef PubMed 89. ↵ Sanjana , N.E. , Cong , L. , Zhou , Y. , Cunniff , M.M. , Feng , G. , and Zhang , F . ( 2012 ). A transcription activator-like effector toolbox for genome engineering . Nat Protoc 7 , 171 – 192 . doi: 10.1038/nprot.2011.431 . OpenUrl CrossRef PubMed 90. ↵ Lee , J.S. , and Zhang , Z . ( 2016 ). O-linked N-acetylglucosamine transferase (OGT) interacts with the histone chaperone HIRA complex and regulates nucleosome assembly and cellular senescence . Proc Natl Acad Sci U S A 113 , E3213 – 3220 . doi: 10.1073/pnas.1600509113 . OpenUrl Abstract / FREE Full Text View the discussion thread. Back to top Previous Next Posted July 24, 2024. Download PDF Supplementary Material Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation Jong-Sun Lee , Tu Dan , He Zhang , Yujing Cheng , Frederick Rehfeld , James Brugarolas , Joshua T. Mendell bioRxiv 2024.07.23.604857; doi: https://doi.org/10.1101/2024.07.23.604857 Share This Article: Copy Citation Tools An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation Jong-Sun Lee , Tu Dan , He Zhang , Yujing Cheng , Frederick Rehfeld , James Brugarolas , Joshua T. Mendell bioRxiv 2024.07.23.604857; doi: https://doi.org/10.1101/2024.07.23.604857 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Molecular Biology Subject Areas All Articles Animal Behavior and Cognition (7644) Biochemistry (17726) Bioengineering (13916) Bioinformatics (42033) Biophysics (21486) Cancer Biology (18635) Cell Biology (25549) Clinical Trials (138) Developmental Biology (13397) Ecology (19940) Epidemiology (2067) Evolutionary Biology (24361) Genetics (15620) Genomics (22541) Immunology (17763) Microbiology (40468) Molecular Biology (17207) Neuroscience (88739) Paleontology (667) Pathology (2842) Pharmacology and Toxicology (4834) Physiology (7659) Plant Biology (15175) Scientific Communication and Education (2047) Synthetic Biology (4304) Systems Biology (9834) Zoology (2272)","source_license":"CC-BY-4.0","license_restricted":false}